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Background: Type 2 diabetes mellitus (T2DM) has been termed one of the fastest 
growing non–communicable diseases of all time. Recent research estimates the 
current prevalence rate of T2DM in New Zealand to be 6.4%, representing 210,000 
New Zealand adults. However, the prevalence rate for prediabetes; the precursor to 
T2DM, is estimated to be much higher, at 25.5%.  
An individual’s awareness of their risk for developing T2DM is essential to mediate 
change, which is the first step in managing the disease. However, studies have shown 
a difference between an individual’s actual disease risk and their perceived risk.  
Aim: To investigate an individual’s perception of risk and compare it to their actual 
risk of developing T2DM in a New Zealand population. A secondary aim is to 
investigate determinants of perceived risk in developing T2DM.  
Methods: 257 New Zealanders over the age of 18 years, nonpregnant and not 
diagnosed with diabetes (type 1 or 2) were recruited for this study. Eligible 
participants took part in an anonymous 10–minute online questionnaire, to assess 
perceived risk using a validated Risk Perception Survey for Diabetes Development 
(RPS–DD) and actual risk of developing T2DM using the Diabetes New Zealand ‘Are 
you at risk?’ calculator. Statistical analysis via SPSS version 26 was performed to test 
for differences between low and high perceived risk groups. Regression analysis 
was conducted to investigate determinants that predict the probability of perceived 
risk in developing T2DM.  
Results: Fifty–three percent (135/257) of participants had an increased actual risk 
(New Zealand Diabetes ‘Are you at risk?’ score >5) of developing T2DM, however 
86% (220/257) of participants perceived their risk of developing diabetes to be low. 
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Significant differences between participants with low perceived versus high 
perceived risk were observed for; GP–recommended testing for CVD/T2DM (56% v 
78%, P=0.02), GP communication about CVD/T2DM risk (24% v 51%, P<0.001), 
prediabetes diagnosis (4% v 24%, P<0.001) and BMI (kg/m2) (24 (22.1, 26.4) v 27.4 
(25.3, 30.8) P<0.001).   
Significant predictor variables of the logistic regression model included; prediabetes 
(OR 8.97 (95% CI 1.61–50.10), P<0.01), eating a diet high in fat and sugar (OR 6.29 
(95% CI 1.83–21.63), P<0.01), family history of T2DM (OR 10.17 (95% CI 3.0 – 
34.47), P<0.001), low comparative disease risk (OR 0.05 (95% CI 0.01 – 0.18), 
P<0.001) and planned lifestyle modifications to reduce risk of T2DM (OR 7.13 (95% 
CI 2.05 – 24.85), P=0.002).  
Conclusion: This study demonstrates that a participant’s perceived risk of 
developing T2DM significantly underestimates their actual risk in 257 participants 
from a New Zealand population. While prediabetes and BMI have been well 
established in the literature for their association with increased risk perception of 
developing T2DM, the role of GP–based communication has not. Further research is 
needed to explore GP–based communication, and the potential impact this has on 
an individual’s understanding of risk in developing T2DM. 
Keywords: prediabetes , risk perception, type 2 diabetes mellitus, Risk 
Perception Survey of Diabetes Development (RPS–DD), actual risk, risk 
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Chapter One – Introduction 
 
Type 2 diabetes mellitus (T2DM) is characterised by elevated blood glucose 
concentrations. In New Zealand T2DM is diagnosed by a glycated haemoglobin 
(HbA1c) value equal to, or above 50mmol/mol ((NZSSD), 2011). Its precursor – 
prediabetes is determined by HbA1c values between 41mmol/mol – 49mmol/mol 
((NZSSD), 2011). Measurement of glycated haemoglobin provides information on 
blood glucose levels over time and the effectiveness of glycaemic control.   
 
Over the past 20 years, diabetes (both prediabetes and T2DM) incidence has been 
on the rise in New Zealand (Jowitt, 2014). The latest available research estimates 
T2DM in New Zealand to be 6.4%, meaning an estimated 210,000 New Zealand 
adults have T2DM (Ministry of Health, 2018/2019). Coppell and colleagues (2013) 
investigated data from the 2008/09 New Zealand Adult Nutrition survey, which 
comprised 4,721 adults over the age of 15 years and found a prevalence rate of 
25.25% for prediabetes.  However, this trend is not specific to New Zealand. In fact 
prevalence rates of T2DM around the world has been termed one of the fastest 
growing non–communicable diseases of all time (Fogelholm et al., 2017). 
 
Perceived risk or risk perception plays a pivotal role in a person’s health status as it 
directly impacts on health behaviour intentions (Paek & Hove, 2017). Risk 
perception is thought to be bi–dimensional, consisting of both an emotional 
dimension (how an individual feels about the risk) and a cognitive dimension (the 




perception is complex, and is influenced by many factors, including risk knowledge 
(Guess, Caengprasath, Dornhorst, & Frost, 2015), Optimistic Bias (a measure of how 
optimistic an individual is about the likelihood of the disease risk) ((Walker, Mertz, 
Kalten, & Flynn, 2003), and degree of personal control around disease development 
(Shaak et al., 2018) to name a few.  
 
In contrast an individual’s actual risk is the biomedical and fundamental underlying 
risk. Measures of actual risk for prediabetes and T2DM range from more exact 
measures via blood analysis tests (such as HbA1c or the Oral Glucose Tolerance Test 
(OGTT)) through to less exact measures such as online risk calculator tools (section 
2.3.3.1 & 2.3.3.2), which calculate a risk score based on an algorithm of risk–based 
questions (Fajardo, Balthazaar, Zalums, Trevena, & Bonner, 2019).  
 
A number of studies have shown significant variances between an individual’s 
perceived risk and their actual disease risk (Heidemann et al., 2019; Hivert, Warner, 
Shrader, Grant, & Meigs, 2009; Joiner et al., 2016; Kim et al., 2007; Kowall et al., 
2017; Pinelli, Berlie, Slaughter, & Jaber, 2009; Yang, Baniak, Imes, Choi, & Chasens, 
2018) with some studies showing a significant underestimation of actual risk (Guo, 
Tang, Zhang, Lommel, & Chen, 2019; Heidemann et al., 2019; Joiner et al., 2016; Kim 
et al., 2007; Kowall et al., 2017).  
 
A German–based study of 2,327 participants without known T2DM found that of 
those with an increased actual T2DM risk (n=639), 79% perceived their risk to be 
absent or slight (Heidemann et al., 2019). A similar trend was observed in another 




without known T2DM found 72% (95% CI 69 – 75) who had prediabetes did not 
perceive they were at risk of developing the disease (Kowall et al., 2017).   
 
An individual’s awareness of their risk for developing T2DM is essential in 
mediating lifestyle and behaviour change to reduce progression of prediabetes to 
T2DM. This is the first step in managing the disease. Early detection and awareness 
of T2DM risk offers a window of opportunity to reverse the disease process for at-
risk individuals, and subsequently avoid adverse outcomes, including 
macrovascular and microvascular complications, neuropathy as well as 
impairments in memory and cognition.  Lean and colleagues (2018) have shown that 
reversal of T2DM is possible in people who have had the condition for up to ten 
years.  
 
The investigation of an individuals’ risk perception and how this compares with the 
model of their actual risk can offer insights into the factors that influence risk 
perception and creates an opportunity to develop strategies to bring risk perception 
more in alignment with actual risk.  
 
There has been no study to date examining people’s perception of risk ,compared 
with their actual risk of developing T2DM in the New Zealand population. This 









1.1 Aims of the study 
 
Primary Aim: To investigate an individual’s perceived risk of developing T2DM and 
compare it to their actual risk of developing T2DM in a New Zealand population.  
Secondary Aim: To identify factors that influence an individual’s perception of risk. 
 
1.2 Hypothesis  
 
Null hypothesis (H0): An individual’s perceived risk is the same as their actual risk 
of developing T2DM in a New Zealand population.  
Alternative hypothesis (H1): An individual’s perceived risk is not the same as their 




The presentation of this thesis is in five chapters which discuss the relationship of 
perceived risk and actual risk of developing T2DM in a New Zealand population. 
Chapter two is a literature review of current studies which investigate the 
perception of risk as well as actual risk of developing prediabetes and T2DM. 
Chapter three describes the methodological procedures carried out for this study. 
Chapter four is a compilation of the findings and results. Chapter five discusses the 
findings and how they relate to the literature. A conclusion of the study as well as 




Chapter Two – Review of the literature 
 
The purpose of this chapter is to offer a review of the literature on the perception of 
risk as well as actual risk of developing prediabetes and T2DM. This chapter includes 
an overview and history of prediabetes and T2DM (section 2.1). Definitions 
associated with T2DM  are  discussed in section 2.2.  Modifiable and non-modifiable 
risk factors as well as tools for assessing diabetes risk are reviewed in section 2.3. 
Long term complications of T2DM, including macrovascular and microvascular 
complications as well as implications for cognition and memory are considered in 
section 2.4. Risk perception and barriers are discussed in section 2.5. Prevention 
strategies and reducing T2DM progression is examined in 2.6.  
2.1 An overview of prediabetes and T2DM 
 
The term ‘diabetes’ was first described in humans as early as the 2nd century AD, 
with Aretaeus of Cappadocia, a Greek physician, communicating the first accurate 
description of the disease (Karamanou, Protogerou, Tsoucalas, Androutsos, & 
Poulakou-Rebelakou, 2016). It was not until the 17th century, Thomas Willis, an 
English doctor formally added the name ‘mellitus’ to the description of diabetes in 
an effort to characterise the very sweet taste of urine (Karamanou et al., 2016).  
 
In the 19th century the discovery of the hepatic glycogenic processes was made, 
through experiments carried out by Oskar Minkowski and Joseph von Mering 
involving the removal of the pancreas of dogs, succumbing them to diabetes 




cells led to the discovery of insulin, which revolutionised and propelled the 
understanding of the disease into an optimistic era of diabetes management 
(Karamanou et al., 2016).   
 
While the first signs of diabetes in humans has been recorded since antiquity, it has 
only been in the modern era that the incidence of both prediabetes and T2DM has 
reached epidemic proportions. The latest Global Report on Diabetes issued by the 
World Health Organisation states diabetes (both type 1 and type 2 diabetes mellitus) 
now affects more than 422 million adults worldwide (World Health Organisation, 
2016).  Currently, individual prevalence rates for type 1 diabetes (an autoimmune 
condition, which requires exogenous insulin for survival) and type 2 diabetes 
mellitus are not available, however of the 422 million adults affected by diabetes, a 
significant proportion are affected by T2DM (World Health Organisation, 2016). 
 
In the late 1990s the Expert Committee on Diagnosis and Classification of T2DM 
defined the term ‘prediabetes’, formally acknowledging those individuals who had 
increased blood glucose levels, but whose levels were not yet high enough to be 
classified as having type 2 diabetes mellitus (American Diabetes, 2014). This 
resulted in diagnostic criteria for prediabetes as either (or both): impaired fasting 
glucose (IFG) (110mg/dL (6.1mmol/L) – 125mg/dL (6.9mmol/L)) and impaired 
glucose tolerance (IGT) (glucose is at 2 h after OGTT) (140mg/dL (7.8mmol/L) – 
199mg/dL (11.0mmol/L)) (American Diabetes, 2014).   
 
In 2003, the criteria for impaired fasting glucose was revised and lowered to 




prevalence rates seen in IGT, however this change was not adopted uniformly. As a 
result the World Health Organisation, and other diabetes organisations have kept 
the original IFG criteria (American Diabetes, 2014).  
 
Since 2011, current recommended guidelines to determine both prediabetes and 
T2DM have been measured by HbA1c (a glycated haemoglobin) in New Zealand, and 
around the world (Table 2.1).  An HbA1c test measures blood glucose levels over a 
3-month period. In New Zealand, an HbA1c measurement between 41–49 
mmol/mol is classified as prediabetes (a fasting plasma glucose (FPG) concentration 
of 6.1–6.9 mmol/L).  And an HbA1c greater than 50mmol/mol is classified as T2DM 
((NZSSD), 2011). 
 
The scope of this thesis focuses on prediabetes and T2DM, however it is worth 
noting there are other forms of the disease, some of which include; Type 1 diabetes 
mellitus, Latent Autoimmune Diabetes of Adulthood (LADA),  and Maturity Onset 
Diabetes of the Young (MODY) or monogenetic diabetes.  
 
LADA is an autoimmune disease, much like type 1 diabetes, however it typically 
presents in adulthood, usually  between the age of 30 – 50 years of age. It can often 
be mistaken for T2DM, due to its slow progression rate, however it is diagnosed by 
the presence of pancreatic islet autoantibodies (Appel, Wadas, Rosenthal, & Ovalle, 
2009).  It is thought to be misdiagnosed in up to 10% of T2DM cases in New Zealand, 






MODY, or monogenetic diabetes often occurs in early adulthood (usually before 25 
years of age). It is an autosomal dominant condition (Ben Khelifa, Barboura, 
Dandana, Ferchichi, & Miled, 2011) with its cause due to mutations on a single gene 
(Best Practice Advocacy Centre New Zealand (Bpac NZ), 2018). 
 
Gestational diabetes, another type of diabetes,  is discussed in section 2.3 Risk factors 
for prediabetes and T2DM.  
 
2.2 Definitions of prediabetes and T2DM 
2.2.1 Prediabetes 
 
The term ‘prediabetes’ is a condition on a continuum of blood glucose 
concentrations and risk of T2DM development (McMurray et al., 2010). It can be 
described as the metabolic midpoint between normoglycaemia and T2DM (Huang, 
Cai, Mai, Li, & Hu, 2016).  
 
Biomedical measures of prediabetes can be defined as either an impaired fasting 
glucose (IFG) or an impaired glucose tolerance (IGT) or a combination of both. IFG 
and IGT have different metabolic processes with differing degrees of long-term 
metabolic risk and disease outcome (Lorenzo et al., 2013).  Fasting plasma glucose 
measurements are recommended when HbA1c is not available or when there are 
concerns about its validity when testing for both prediabetes and T2DM ((NZSSD), 





IFG is less prevalent than IGT across the population (Abdul-Ghani, Tripathy, & 
DeFronzo, 2006). Prevalence of both IFG and IGT increases with age, however IGT 
is more common in women under the age of 55 years, while IFG is twice as likely in 
men (Abdul-Ghani et al., 2006). Reasons for this are thought to be due to the reduced 
hepatic sensitivity to insulin, resulting in higher plasma glucose levels in men, while 
women have higher circulating levels of oestrogen and progesterone – hormones 
which can reduce whole body insulin sensitivity (Hilawe, Yatsuya, Kawaguchi, & 
Aoyama, 2013).  Prediabetes can also be defined by a fasting plasma glucose (FPG) 
and HbA1c (Table 2.1). 
 
  
Table 2.1 Global classifications of prediabetes & T2DM 
 New Zealand1 United 
Kingdom2 
Australia3 United States4 World Health 
Organisation5 
Normoglycaemia 
- FPG (mmol/l) 





















- FPG (mmol/l) 
- HbA1c (mmol/mol) 
 
 
6.1 – 6.9 
41 – 49 
 
5.5 – 6.9 
42 – 47 
 
6.1 – 6.9 
41 – 47 
 
100 – 125mg/dL* 
5.7 – 6.4 %* 
 
6.1 – 6.9 
– 
T2DM 
- FPG (mmol/l) 

















1((NZSSD), 2011) 2(Diabetes.co.uk, 2019; Diabetes.org.uk, n.d), 3(Australian Diabetes Society, n.d), 4 (American 
Diabetes, 2014) 5(World Health Organization, 2019) 
 
*The United States use % as an HbA1c unit, and mg/dL as an FPG unit, whereas the rest of the world use 
mmol/mol as a measure for HbA1c and mmol/l for FPG. 
 
FPG = Fasting plasma glucose  
HbA1c = glycated haemoglobin  
 
2.2.1.1 Impaired fasting glucose (IFG) 
 
Impaired fasting glucose (IFG) is thought to be a result of impaired hepatic glucose 




plasma insulin (Abdul-Ghani et al., 2006). Individuals with IFG have higher than 
normal glucose levels upon waking due to impaired basal insulin secretion and 
reduced hepatic insulin sensitivity (Unwin, Shaw, Zimmet, & Alberti, 2002). In 
essence, individuals with IFG tend to have hepatic insulin resistance and normal 
skeletal muscle insulin sensitivity (Nathan et al., 2007).  
 
2.2.1.2 Impaired glucose tolerance (IGT) 
 
In contrast, impaired glucose tolerance (IGT) is associated with impaired insulin 
sensitivity in peripheral tissues, in particular, in skeletal muscle  (Unwin et al., 
2002). Skeletal muscle is the primary site of glucose utilisation postprandially 
(Unwin et al., 2002).  Individuals with IGT typically exhibit normal hepatic insulin 
sensitivity (Nathan et al., 2007).  
 
2.2.1.3 Combined IFG and IGT  
 
Individuals who present with both IFG and IGT are considered to be at the greatest 
risk of development and progression to T2DM as well as associated cardiovascular 
disease and in some cases, raised inflammatory responses (Unwin et al., 2002). This 
is because they have dual impairments of hepatic glucose regulation and reduced 
insulin sensitivity in periphery tissue, as well as significantly impaired lipoprotein 
profiles (Lorenzo et al., 2013).  One of the largest meta–analysis review of global 
cohorts which included over 55,000 participants from the Netherlands, Asia, USA, 
Middle East and Mexico, investigated the annual incidence and relative risk of T2DM. 




T2DM) in individuals with combined IGT and IFG, with a conversion rate of 15–19%, 
compared with isolated IGT (4–6%) and IFG (6–9%) (Gerstein et al., 2007).   
 
The Diabetes Heart and Health Survey (DHAH) which was carried out in Auckland, 
New Zealand between 2002 – 2003 showed the prevalence rates of IGT and IFG to 
be 21.9% and 9.3% respectively (Sundborn et al., 2007). In a more recent study, also 
carried out by New Zealand-based researchers,  a cumulative T2DM incidence rate 
of 5%  was found in 14,043 prediabetic adults after three years from being newly 
diagnosed with prediabetes (Teng et al., 2019). International progression rates of 
prediabetes to T2DM range from 2 – 18% per year (Teng et al., 2019). 
 
2.2.2 Type 2 Diabetes Mellitus (T2DM) 
 
Around the world there are differences in HbA1c measures for defining when a 
person is termed to have T2DM (Table 2.1). In New Zealand T2DM is defined by an 
HbA1c greater than 50mmol/mol or a FPG greater than or equal to 7 mmol/l (Table 
2.1) ((NZSSD), 2011). The HbA1c measure offers relatively low biological variability 
as well as reliable associations with macrovascular outcomes. The measure is also 
more convenient for patients, who do not need to fast or provide repeated blood 
glucose measures unlike the FPG and oral glucose tolerance test (OGTT) ((NZSSD), 
2011).  
 
The disadvantages of FPG include the relatively large biological variability, it is also 




neuropathy and macrovascular outcomes compared with HbA1c (Elley, Kenealy, 
Robinson, & Drury, 2008; Selvin et al., 2004).  
 
The Oral Glucose Tolerance Test (OGTT) has been the gold standard measure for 
determining if a person has T2DM in New Zealand up to 2011, when the HbA1c was 
introduced. An advantage of the OGTT is its accuracy, often diagnosing a larger 
number of asymptomatic T2DM cases compared with the HbA1c (Hussain, 2016). 
However the OGTT is more labour-intensive for patients, as well as being more 
costly from a laboratory perspective (Hussain, 2016). 
 
2.3 Risk factors for prediabetes and T2DM 
There are many factors which increase a person’s risk for developing prediabetes 
and T2DM. Some key risk factors include: being overweight or obese, suboptimal 
diet and exercise, smoking, inadequate sleep, genetics, ethnicity, family history, 
gestational diabetes and age (Bellou, Belbasis, Tzoulaki, & Evangelou, 2018; Jowitt, 
2014; Khaodhiar, Cummings, & Apovian, 2009; Yaggi, Araujo, & McKinlay, 2006; 
Yang et al., 2018; Zhang et al., 2019) (Kirkman et al., 2012; Plows, Stanley, Baker, 
Reynolds, & Vickers, 2018). 
 
Risk factors for T2DM can be classified as either modifiable (section 2.3.1) or non-
modifiable (section 2.3.2). Modifiable risk factors can be controlled or changed by 
the individual to help reduce their risk. These include controlling weight gain, eating 
a healthy balanced diet, not smoking, as well as getting adequate sleep at night. Non-
modifiable risk factors include factors that cannot be manipulated or controlled by 









“New Zealand is the fourth most obese country in the OECD region”, according to Boyd 
Swinburn, Professor of Population Nutrition and Global Health at the University of 
Auckland (Sydney Ideas, 2019). With 32.2% of New Zealand adults over the age of 
15 years classified as obese (OECD, 2017). The United States, Chile and Mexico 
taking podium positions of 1st, 2nd and 3rd, respectively (OECD, 2017).  While the 
exact cause of T2DM is not completely understood, obesity is strongly associated 
with insulin resistance, and as a result, prediabetes and T2DM (Barazzoni, Gortan 
Cappellari, Ragni, & Nisoli, 2018).   
 
Adipose tissue, once thought of as a simple storage solution for unused energy, is 
actually an endocrine factory in its own right – producing hormones, adipocytokines 
and other substances which impact the production of insulin as well as insulin’s 
ability to work effectively in the body (Khaodhiar et al., 2009).   
 
Obesity reduces the ability of the liver and muscles to utilise glucose, resulting in 
both an increased production of insulin from the pancreatic beta cells as well as a 
resistance to insulin at hepatic and muscular sites (Khaodhiar et al., 2009). The 
increased production of inflammatory markers, namely Interleukin–6 (IL–6) and 
tumour–necrosis factor–α (TNF–α) as a result of an obesogenic state are also 
implicated in the development of T2DM (Khaodhiar et al., 2009). A systematic 




found strong associations between increased levels of inflammatory cytokines 
(Interleukin–1β (IL–1β), IL–6, Interleukin–18 (IL–18), C–reactive protein 
(CRP)),TNF–α and T2DM risk (Liu et al., 2016). 
 
In a recent review of 86 studies, obesity, as measured by body mass index (BMI) had 
a statistically significant and strong positive association with T2DM development 
(Bellou et al., 2018). Furthermore, Bellou and colleagues (2018) found the metabolic 
health of an obese individual had an impact on the degree of risk of developing 
T2DM. Obese individuals who were metabolically unhealthy (ie were hypertensive, 
had dyslipidaemia and/or had hyperglycaemia) had a 10-fold increase in risk of 
T2DM development compared to metabolically healthy obese individuals, who only 
had a four-fold increased risk.  
 
Another systematic review of 89 studies which investigated co-morbidities 
associated with T2DM, showed a significant association between obesity (as defined 
by BMI) and 18 co-morbidities including many types of cancers and cardiovascular 
disease (Guh et al., 2009). However, the strongest association was observed for 
T2DM in females who were overweight (RR = 3.92 (95% CI: 3.10–4.97)) and obese 
(12.41 (9.03–17.06)) (Guh et al., 2009). 
 
There is consistent support for obesity management to reduce the progression from 
prediabetes to T2DM (American Diabetes, 2018). Furthermore, the reduction in 
weight (ideally 7% of total bodyweight) earlier rather than later in the 
hyperglycaemic state can result in reversal of beta-cell dysfunction, before insulin 





The Clinical Guidelines for Weight Management in New Zealand Adults (2017) 
outlines the increase in risk for developing T2DM (as well as hypertension and 
cardiovascular disease) with elevated waist circumference (WC) measurements 
(WC>102 cm for men; WC>88cm for women) and increasing BMI levels above 24.9 
kg/m2. The guidelines also advocate for at least 5% loss in body weight to achieve 
positive metabolic health outcomes (such as improved insulin sensitivity , with 
additional weight loss above 5% body weight conferring additional disease risk 
reduction benefits (Ministry of Health, 2017).  
 
2.3.1.1.1 Gestational diabetes mellitus (GDM) 
 
Gestational diabetes mellitus (GDM) can be defined as abnormal glucose metabolism 
during pregnancy. It is a common complication, affecting approximately 14% of 
pregnancies, globally (Plows et al., 2018).   Both GDM and T2DM share common risk 
factors including overweight and obesity (Kim et al., 2010). 
 
The cause of GDM is thought to be due to both reduced insulin sensitivity and an 
inability for the pancreatic beta cells to produce the required amount of insulin to 
meet demands for pregnancy (Lacroix, Kina, & Hivert, 2013). While gene-variant 
and Genome-Wide Association Studies (GWAS) have indicated a genetic component 
to insulin dysregulation observed in GDM (Kwak et al., 2012; Mao, Li, & Gao, 2012), 
maternal overweight and obesity is thought to be the main contributor to the 
prevalence rates seen in GDM (Kim et al., 2010). A two-year analysis of 23,904 




spanned across seven US states concluded nearly half of all GDM cases could be 
prevented if overweight and obese women (BMI≥25kg/m2) had a GDM risk equal to 
women of a normal BMI (18.5 – 24.9kg/m2) (Kim et al., 2010). 
 
The prevalence of GDM in New Zealand is not completely known. A retrospective 
study which analysed a cohort of nearly 7000 pregnant women from the Growing 
Up in New Zealand study found a prevalence rate of 6.2% (Lawrence, Wall, & 
Bloomfield, 2019).  
 
GDM can have adverse health outcomes for both the baby (macrosomia, increased 
risk of CVD and T2DM later in life as well as hypoglycaemia immediately after birth) 
and the mother (increased risk of developing T2DM, pre–eclampsia and increased 
risk of future pregnancies with GDM)(Lawrence et al., 2019).  
 
 
2.3.1.2 Diet & Exercise 
 
The relationship between diet and T2DM was first observed around 3,000 years ago 
when T2DM was seen as a disease of the rich, whose diet consumed mostly of oil, 
flour and sugar (Sami, Ansari, Butt, & Hamid, 2017). Mortality rates of T2DM were 
also tracked during both World Wars, where rates declined in war-torn countries as 
a result of famine but flourished in countries untouched by war, where food was 
abundant (Sami et al., 2017). Since then, research has delved into the details of the 
human to diet to understand the exact constituent’s that underpin T2DM risk 
development. Results from a recent umbrella review of meta-analysis showed a 




beverages) and risk of T2DM development (Neuenschwander et al., 2019). Similarly, 
a positive relationship was also seen for red and processed meats  and risk of T2DM 
development in the review. Conversely a diet rich in wholegrains and cereal fibre 
have shown an inverse relationship with T2DM risk (Neuenschwander et al., 2019). 
These findings have been supported by an expert review of both observational 
studies and randomised controlled trials which found a positive association for 
cereal fibres, unsaturated fatty acids and an inverse association for foods with  
added sugar, a high glycemic load as well as sugar sweetened beverages (Palacios, 
Kramer, & Maki, 2019).   
Today there is little doubt that a suboptimal diet (one high in sugar and low in fibre), 
and lack of exercise play a crucial role in the development of both prediabetes and 
T2DM. So much so, that healthy lifestyle strategies such as the ‘Global strategy on 
diet, physical activity and health’, have been developed by the World Health 
Organisation, with similar initiatives employed in most government health 
departments around the globe (WHO, 2004). Supporting government initiatives, is 
a significant amount of literature, such as the PREVIEW trial and the Finnish 
Diabetes Prevention Study (DPS) which provide strong evidence for a focus on 
lifestyle modification in the form of healthy diet and exercise (Fogelholm et al., 2017; 
Tuomilehto et al., 2001). 
 
The Finnish (DPS) was the first randomised controlled trial to demonstrate  
lifestyle-change intervention can prevent T2DM in high-risk individuals (Lindstrom 
et al., 2003; Lindstrom et al., 2013). The study recruited 522 men and women with 
impaired glucose tolerance (mean age 55yrs, mean BMI: 31kg/m2) who were 




counselling aimed at reducing weight through healthier eating and increased 
physical activity) or standard care (control) consisting of oral and written (2-page 
booklet)  information on healthy eating and physical activity at baseline and at 
annual follow–ups. Results during the trial showed a 58% reduction in T2DM risk in 
the intervention group (P<0.001). Furthermore, the cumulative incidence of T2DM 
after four years was significantly lower in the intervention group (11% (CI 95% 6 – 
15%) compared to the control group (23% (CI 95% 17–29%) (Tuomilehto et al., 
2001). These results are reflective of the significant net weight loss seen in the 
intervention group at the one (4.2kg ±5.1kg) and two (3.5kg ±5.5kg) year follow–
ups compared with the control group, who had a net weight loss of 0.8kg ±3.7kg and 
0.8kg ±4.4kg respectively (Tuomilehto et al., 2001).  
 
A similar trend was also reported in a recent review of 14 studies with nearly 1 
million participants. Participants who had the healthiest lifestyle (as defined by 
maintaining a healthy weight, eating a balanced diet, having at least 30 minutes of 
exercise/day and avoiding smoking and excessive alcohol consumption) had a 75% 
lower risk of developing diabetes (HR 0.25 [95% CI 0.18, 0.35]) (Zhang et al., 2019).  
 
Bellou and colleagues (2020) found convincing evidence for the role of poor diet and 
increased risk of T2DM development in a review of 86 studies. In particular: 
increased consumption of processed meats and sugar-sweetened beverages showed 
strong evidence for an increased risk for T2DM development.  Conversely, increased 
consumption of wholegrain foods showed strong evidence for a protective effect 




reduced the rate of gastric emptying, enabling a slow release of glucose into the 
blood stream (Bellou et al., 2018). 
 
Exercise plays a key role in mediating T2DM risk development, via increased  
glucose utilisation and insulin sensitivity at skeletal muscle sites, thereby regulating 
blood glucose levels (Asif, 2014). Exercise also results in energy expenditure, which 
reduces adipose tissue stores, assisting with weight maintenance (Asif, 2014).  
 
The Diabetes Prevention Program Research Group (2002) demonstrated a 
reduction in T2DM incidence of 58% (95% CI 48–68%) by using a lifestyle 
intervention, which included 150minutes/week of exercise, in 3,234 participants 
without T2DM.  When comparing this with the metformin (850mg twice a day) 
intervention only a 31% (95% CI 17–43%) reduction in T2DM incidence was 




Smoking is thought to impact T2DM risk via both direct and indirect mechanisms 
involving insulin regulation (Artese, Stamford, & Moffatt, 2019).  Smokers tend to 
have greater central adiposity compared with non-smokers resulting in increased 
insulin resistance (Reaven & Tsao, 2003) despite the appetite-reducing  
mechanisms of nicotine (Kawamoto et al., 2010). Direct mechanisms on insulin 
regulation is thought to be via increased secretions of hormones such cortisol and 
catecholamines that counter the effects of insulin, resulting in insulin resistance 




protein produced by adipocytes which increase insulin sensitivity has been found in 
smokers compared with non-smokers (Kawamoto et al., 2010). A cross sectional 
study of 724 Japanese men without a prior history of T2DM demonstrated via 
multilinear regression analysis, an inverse relationship with serum high molecular 
weight (HMW) adiponectin and BMI as well as smoking frequency (Kawamoto et al., 
2010).   
 
A 2017 systematic review and meta–analysis of 22 articles involving 343,573 
participants examined the relationship between smoking status, intensity, cessation 
and risk of developing T2DM in Japan (Akter, Goto, & Mizoue, 2017). Results from 
the meta-analysis found a linear dose-response relationship between T2DM risk and 
the number of cigarettes consumed. For each increase of 10 cigarettes smoked per 
day there was a 16% increase in risk of T2DM. Additionally there was a negative 
relationship between T2DM risk and smoking cessation post 5-years, with a steady 
decrease in risk for each year of smoking cessation. This risk was comparable to a 





Sleep deprivation has been linked to insulin resistance and glucose dysregulation  
(Yaggi et al., 2006).  The mechanisms of action in which sleep deprivation disrupts 
these metabolic functions are thought to be due to changes in hormonal and 
endocrine functions which influence carbohydrate metabolism as well as cortisol 





A study which involved a cohort of male participants from the Massachusetts Male 
Aging Study found a U–shaped pattern to the number of hours of sleep attainted per 
night and risk of developing T2DM (Yaggi et al., 2006). Males who had less than 6 
hours of sleep per night were twice as likely to develop T2DM compared to males 
who had 7 hours sleep per night. Conversely, males who reported having more than 
8 hours of sleep per night were three times as likely to develop T2DM compared to 
males who had 7 hours sleep  per night (Yaggi et al., 2006).   
 
A recent meta-analysis of ten studies which included over 18,000 cases of T2DM also 
confirmed a U-shaped relationship between hours of sleep per night and risk of 
developing T2DM over a two to 16 year follow up period (Shan et al., 2015). The 
relative risk for T2DM was 1.09 (95% CI 1.04–1.15) per one hour less than seven 
hours sleep per night, and the relative risk was 1.14 (95% CI 1.03–1.26) per one 
hour of additional sleep beyond 7 hours (Shan et al., 2015). 
 
2.3.2 Non–modifiable risk factors 
 
2.3.2.1 Genetic factors 
 
With the modern advances in gene-technology and the sequencing of the human-
genome, the identification of genes associated with the development and 
progression of T2DM has grown. As a result there are 120 distinct genetic loci now 
documented, explaining approximately 20% of all T2DM cases  (Szabo, Mate, Csep, 





A recent study by Guo and colleagues (2019) investigated the genetic correlation 
between resting heart rates (RHR) and metabolic disorders including T2DM from  
UK Biobank data (n = 428,250).  Summary-level data was available for 74,124 cases 
of T2DM. Findings from the study found statistically significant genetic correlations 
between RHR and T2DM (rg = 0.22; 95% CI 0.18 to 0.26; p = 1.99 × 10−22) and six 
metabolic characteristics including; body mass index (BMI), waist to hip ratio 
(WHR), fasting insulin, fasting glucose, triglycerides and high–density lipoprotein 
(HDL); rg range −0.12 to 0.24; p < 0.05) (Guo, Chung, et al., 2019).  
 
Analysis from transcriptome-wide association scans (TWAS) discovered seven 
genes (SMARCAD1, RP11–53O19.3, CTC–498M16.4, PDE8B, AKTIP, KDM4B, and 
TSHZ3) that were statistically separate and shared between RHR and T2DM in the 
cardiovascular and nervous system tissue (Guo, Chung, et al., 2019). This study 
offers evidence for a genetic correlation between high RHR and metabolic orders 
such as T2DM (Guo, Chung, et al., 2019).    
 
In a twin study of 40 pairs of monozygotic and 46 pairs of dizygotic twin females 
Cohen and colleagues (2006) found approximately one third of the variation in 
HbA1c levels could be explained by the glycation gap (GG), a measure of the 
difference between HbA1c concentrations and estimated concentrations of the 
enzyme fructosamine (Cohen et al., 2006).  GG was more strongly associated with 
monozygotic twins than dizygotic, r=0.65 and r=0.48 respectively (Cohen et al., 
2006).  Twin studies offer the opportunity to identify genetic contributions to the 





2.3.2.2 Ethnicity   
 
The incidence rates of prediabetes and T2DM are over represented in ethnic groups 
including Asian, Māori and Pacific people, among others (Jowitt, 2014; Metcalf, Kyle, 
Kenealy, Sundborn, & Jackson, 2018). Why certain ethnic groups have higher 
prevalence rates of abnormal glycaemia is complex and multifactorial. Genetic risk 
factors such as the ‘thrifty genotype’ has been suggested as a possible contribution 
to the diabetes development in people of Pacific background (Jowitt, 2014).  
Differences in metabolic markers (including; impairment of beta-cell function, 
dysregulation of glucose and impaired insulin sensitivity) in different ethnic groups 
have also been reported, irrespective of age or BMI (Jowitt, 2014).  Additional 
reasons for ethnic disparity include access to and utilisation of high quality 
healthcare (Ellison-Loschmann & Pearce, 2006; Jatrana, Crampton, & Norris, 2011). 
 
Data from a cross-sectional study (The Auckland Diabetes, Heart and Health Survey) 
of 3,559 participants, found ethnic differences in mean HbA1c levels of both normal 
and abnormal glycaemic participants (Metcalf et al., 2018). Results showed, that 
after controlling for age and gender, HbA1c levels were higher for Pacific by 5.5 
(SE=0.25)mmol/mol, Māori by 2.5 (SE=0.24)mmol/mol and Asian by 2.3 
(SE=0.40)mmol/mol compared with  New Zealand Europeans. It is worth noting the 
higher prevalence rates of smoking and increased BMI in both Māori and Pacific 
participants in this study, both of which are risk factors for T2DM as well. Why 
HbA1c levels are higher in ethnic minorities is a likely result of a complex–




glycation, reduced access to healthcare as well as factors associated with 
socioeconomic status (Metcalf et al., 2018).   
 
Access and utilisation of healthcare for ethnic minorities has also been examined as 
a possible explanation for higher rates of prediabetes and T2DM. Between 1988 to 
1990, the New Zealand Workforce survey was conducted, involving 5,677 
multicultural staff from worksites in Tokoroa and Auckland (Scragg, Baker, Metcalf, 
& Dryson, 1991). The cross-sectional survey found prevalence rates of newly 
diagnosed T2DM to be 9.7% for Màori, 7.7% for Pacific people and just 1.7% for 
Europeans. A decade on, between 2002 and 2003, the Diabetes Heart and Health 
(DHAH) study demonstrated prevalence rates for newly diagnosed T2DM had 
decreased for both Màori (3.8%) and Pacific people (4%) (Sundborn et al., 2007). 
One reason for this decrease in prevalence rates of newly diagnosed T2DM in Màori 
was thought to be attributed to the 1991 health reforms which initiated growth of 
new Màori healthcare providers (Ellison-Loschmann & Pearce, 2006; Sundborn et 
al., 2007). During this time Màori healthcare providers grew from just 13 in 1994 to 
over 240 in 2004 resulting in earlier and increased access to healthcare for Màori 
(Ellison-Loschmann & Pearce, 2006; Sundborn et al., 2007).  
 
Data from a third wave (2004-2005) of the longitudinal Survey of Family, Income 
and Employment (SoFIE) investigated ethnic differences in financial barriers to 
prescription medication access in 18,320 New Zealand adults (Jatrana et al., 2011). 
Of the 18,320 adults surveyed, 14,315 (78.1%) were New Zealand European, 1,975 
(10.8%) were Màori and 800 (4.4%) were Pacific. Results from the analysis showed 




12-month period were higher for Màori (OR 2.98 (95% CI 2.56 – 3.47) and Pacific 
people (OR 3.52 (95% CI 2.85 – 4.35) compared with New Zealand European 





T2DM risk increases as a direct result of the aging process, and is associated with 
reduced capacity of pancreatic beta-cell function and reduced insulin sensitivity 
resulting in glycaemic dysregulation (Kirkman et al., 2012).   
 
Coupled with age-related risk, older-aged population groups also tend to have 
reduced physical activity levels. This was highlighted in results from the latest New 
Zealand Ministry of Health 2018/2019 Survey where 16% of 65–74 year olds and 
31% of  ≥75–year olds were reported doing less than 30 minutes of physical activity 
per week (Ministry of Health, 2018/2019). This is well under current New Zealand 
physical activity guidelines for older people of 30 minutes of moderate physical 
activity on at least five days per week (Ministry of Health, 2013).  
 
According to the National Diabetes Statistics Report, published in 2017, by the  
Centres for Disease Control and Prevention (CDC), approximately 30 million US 
adults have T2DM (Centers for Disease Control and Prevention, 2017). This statistic 
is over-represented in the ≥65 year demographic, with 25.2% reported as having 
T2DM (Centers for Disease Control and Prevention, 2017).  A similar trend exists in 




and 45.2% represented by  the 55–64 year and  ≥ 65–year demographic, 
respectively (Ministry of Health, 2018/2019).  
 
Researchers from the Centre for Disease Control and Prevention (CDC) forecast 
prevalence rates of diabetes will double over the next two decades due to the aging 
population, even if incidence rates flatten (Boyle, Thompson, Gregg, Barker, & 
Williamson, 2010).  
 
 
2.3.3 Who should be assessed for T2DM risk in New Zealand?  
 
The New Zealand Society for the Study in Diabetes (NZSSD) is the nation’s leading 
body on scientific and clinical standards in diabetes. Their position statement on the 
diagnosis and screening for T2DM recommends screening to commence in low-risk, 
asymptomatic men and women at 45 years and 55 years respectively ((NZSSD), 
2011).  This is alongside CVD screening recommendations.  
Individuals with risk factors for T2DM, such as; ischaemic heart disease, vascular 
disease, obesity (BMI>30kg/m2), family history of diabetes, taking long-term 
antipsychotic or steroid medication, or a history of gestational diabetes in 
pregnancy should be screened from 25 years of age ((NZSSD), 2011).  
Children and young adults who are obese (BMI>30kg/m2) should be routinely 
screened if; they are of Pacific, Māori or Asian/Indian ethnicity or if there has been 




Risk factors can be used as a means for determining a person’s risk of developing 
T2DM and this is discussed in section 2.3.3.1 below.  
 
2.3.3.1 Assessment of actual risk using risk calculator tools 
 
Measuring actual risk of T2DM development can be done via invasive and non-
invasive methods. Invasive methods include blood analysis of biochemical markers 
such as HbA1c or fasting plasma glucose (FPG) as discussed in section 2.2 of this 
chapter.  Less invasive techniques include risk calculator tools, which are based on  
a series of questions around modifiable (ie physical activity levels, diet and BMI) and 
non-modifiable risk factors (ie family history, age and ethnicity)  for developing 
T2DM. Each question in the risk calculator tool has a numeric value. The numeric 




2.3.3.2 Risk calculator tools 
 
The development of online risk calculator tools in recent years has led to the ability 
for individuals to assess their own disease risk in greater numbers than ever before 
(Skolbekken, 2019). This has provided an opportunity for people to feel empowered 
and in charge of their health. However it also has the potential to negatively impact 
individuals who receive a higher calculated risk score compared with their actual 




The Diabetes New Zealand ‘Are you at risk?’ calculator comprises of eight questions 
which ask about; weight, physical activity levels, diet, family history of diabetes, 
ethnicity, gestational diabetes, and age. Responses to these questions categorise 
individuals either into a low risk category (score between 3–5) and an increased risk 
category (score greater than 6).  
Despite contacting Diabetes New Zealand and conducting a search of the literature, 
it was not possible to gain insight into how or when the risk assessment tool was 
developed. Email correspondence from Diabetes New Zealand –  
“The Risk Assessment tool came from our Diabetes NZ Auckland branch which 
produced it (the risk assessment tool) following a consensus discussion with their 
consultant medical advisor at the time……no report from the consensus discussion is 
available from the Diabetes NZ Auckland branch..……the risk calculator will be 
reviewed at appropriate intervals’’ 
Comparing similar risk assessment tools from around the world. The  Australian 
T2DM Risk Assessment tool (AUSDRISK) comprises of 11 questions including: age, 
gender, ethnicity, country of birth, family history, history of high blood sugar, 
medication use for blood pressure, smoking status, fruit and vegetable intake, 
physical activity level and waist measurement. Results from these questions rank 
individuals on a 6-point risk continuum from low risk (0–5 points) up to very high 
risk (20+ points).  AUSDRISK assesses the risk of developing T2DM in the next five 
years, rather than an immediate diabetes risk, which is dissimilar to other risk tools 
discussed in this section.  AUSDRISK was developed by the Baker IDI Heart and 
Diabetes Institute and has been validated in the Australian Diabetes, Obesity and 




The Diabetes UK Risk Calculator was developed in conjunction with Diabetes UK, 
the University of Leicester and the University Hospital of Leicester NHS trust, and 
comprises of eight questions, similar to the Diabetes New Zealand risk calculator. 
Questions differ slightly in that the UK Risk Calculator asks about gender, waist 
circumference measurement and blood pressure, however it omits lifestyle 
questions around diet and physical activity levels. Responses from the Risk 
Calculator are categorised into one of four risk groups: low risk (score 0–6), 
increased risk (7–15), moderate risk (16–24) and high risk (25–47).  
The American Diabetes Association (ADA) first launched their diabetes risk 
calculator in the early 1990s. The risk calculator was modelled on data from the 
1999–2004 NHANES study, which was subsequently validated through a number of 
large-scale studies including; the Atherosclerosis Risk in Communities (ARIC) study, 
2005–6 NHANES study and the Cardiovascular Health Study (CHS) (Stiglic & 
Pajnkihar, 2015).  
The ADA risk calculator is based on nine questions which include: age, gender, 
history of gestational diabetes and family history of diabetes, blood pressure, 
physical activity levels, ethnicity as well as height and weight. Responses are then 
calculated into either a low risk (less than 5) or high risk (greater than 5). From the 
studies in the literature review (Table 2.2) the ADA risk calculator is the most 
frequently reported risk calculator used to assess T2DM actual risk.  
 
A recent study by Fajardo and colleagues (2019) evaluated thirty–five risk 




and the ADA. The Diabetes New Zealand ‘Are you at risk?’ calculator was not 
included in the evaluation.  Findings from the study indicated nearly half of the risk 
calculators do not state the underlying model in which the calculators are based on, 
making it difficult for individuals as well as health professionals to correlate 
differences in risk results between multiple risk calculator used (Fajardo et al., 
2019). This limitation was also observed when researching the Diabetes New 
Zealand ‘Are you at risk?’ calculator for this research project.  
 
Only 32% of the risk calculator tools evaluated by Fajardo and colleagues (2019) 
used visual aids in communicating numeric risk information, a gold standard 
measure in ensuring results of risk information is understood by the general 
population (Fajardo et al., 2019). While visual aids were used in the questions of the 
Diabetes New Zealand ‘Are you at risk’ calculator, there were no visual aids to assist 
with communicating risk information based on the calculated risk score.  This is an 
important point to consider, given the low levels of health literacy in New Zealand 
(discussed further in 5.2.9).  
 
A review by Buijsse and colleagues (2011) found risk scores based on forty-six risk 
assessment tools provided relatively good predictability of T2DM development 
when used in the population that were designed for; but show wide variability 





The Diabetes New Zealand ‘Are you at risk’ calculator was chosen for the current 
project as it was the risk calculator that most aligned with the target population 
being investigated, despite some limitations of the calculator (as discussed already 
in this section and further in section 5.3.1).  
 
2.4 Type 2 diabetes mellitus and long–term complications 
 
T2DM is a progressive and chronic condition characterised by both insulin 
resistance and an insulin insufficiency (Asif, 2014). Both insulin resistance and 
insufficiency result in significantly elevated blood glucose concentrations increasing 
the risk for adverse outcomes (Asif, 2014).  Unlike some diseases, T2DM offers a 
window of opportunity to reverse the disease process and subsequent adverse 
outcomes including macrovascular complications (section 2.4.1) impairments in 
memory and cognition (section 2.4.2) and microvascular complications (section 
2.4.3).   
 
Studies have shown an association between prediabetes and T2DM and increased 
risk of  macrovascular complications (Ford, Zhao, & Li, 2010; Huang et al., 2016; 
Sarwar et al., 2010) increased risk of decline in cognition (Geijselaers et al., 2017; 
Zheng, Yan, Yang, Zhong, & Xie, 2018) chronic kidney disease and diabetic 
retinopathy and nephropathy (Adler et al., 2003; Lee et al., 2015; Tabak, Herder, 
Rathmann, Brunner, & Kivimaki, 2012; Wasserman, Wang, & Brown, 2018),  
 
Recent research such as the PREVIEW and DiRECT trials have had significant results 




through lifestyle modifications in diet and exercise (Fogelholm et al., 2017; Lean et 
al., 2018). Lean and colleagues (2018) have shown that reversal of T2DM is possible 
in people who have had the condition for up to ten years. The window of opportunity 
to reverse T2DM highlights the importance of early intervention around individual 
diabetes risk knowledge and communication strategies. The UK Prospective 
Diabetes Study (UKPDS), a landmark trial, investigated different therapy treatments 
of 4,209 participants who had been newly diagnosed with T2DM in 4, over a 6–year 
period found reduced beta-cell functionality at the time of diagnosis (Turner et al., 
1995). Furthermore, this reduction in beta-cell function continued to decline over 
time.  Results from the UKPDS trial showed that a reduction in just 1% of HbA1c 
levels in patients recently diagnosed with T2DM have a significant risk reduction for 
long-term complications, such as vascular disease, cataract extraction, myocardial 
events and stroke (Turner et al., 1995).  This finding was supported by another 
landmark trial – the Diabetes Control and Complications Trial (DCCT), which 
involved 1,441 insulin-dependent participants with type 1 diabetes mellitus who 
underwent intensive diabetes therapy for glycaemic control  (Shamoon et al., 1993). 
Of the 1,441 participants, 726 presented with no retinopathy at initiation of the 
study and were classified as the primary-prevention cohort. The remaining 715 
presented with mild retinopathy and were classified as the secondary-prevention 
cohort. Each cohort was randomly assigned to received either intensive insulin 
therapy guided by an insulin-pump and glucose monitoring or usual care (one to 
two daily injections). Results after 6.5 years demonstrated a risk reduction for 
developing retinopathy of 76% (95% CI 62–85%) compared with usual care in the 




therapy reduced the development of retinopathy by 54% (95% CI 39–66%) 
compared to usual care (Shamoon et al., 1993). 
 
 
2.4.1 Macrovascular complications 
 
Macrovascular disease involves the large blood vessels of the body, mainly affecting 
coronary arteries as well as the aorta with typical pathogenic progression being 
cardiovascular disease and stroke (Fowler, 2008).  
 
Prediabetes and T2DM is associated with an increased risk of cardiovascular disease 
and vascular-related events (Wasserman et al., 2018). A meta-analysis of 53 
prospective cohort studies spanning over 1.6 million normoglycaemic and 
prediabetic participants, showed prediabetic participants were associated with an 
increased risk of cardiovascular disease (RR 1.13 (IFG–ADA) 1.26 (IFG–WHO) and 
1.30 (IGT)) and coronary heart disease (RR (1.10 (IFG–ADA), 1.18 (IFG–WHO) and 
1.20 (IGT) (Huang et al., 2016).  
 
Similar trends were also observed from the Emerging Risk Factors Collaboration 
study, which investigated 102 cohorts of nearly 700,000 participants across 25 
countries. Results from analysing participant blood glucose levels, found those with 
T2DM resulted in an approximate two-fold increase in risk of vascular diseases such 
that: the adjusted hazard ratio for coronary heart disease was 2.00 (95% CI 1.83–





Although strong associations were seen for vascular risk in individuals with T2DM, 
such associations were not seen as strongly in those with impaired fasting glucose, 
which is logical, as blood glucose concentrations are not as high.  Compared with 
fasting blood glucose concentrations between 3.90–5.59mmol/L, the hazard ratio 
for coronary heart disease was 1.11 (95% CI 1.04–1.18) and 1.17 (95% CI 1.08–
1.26) for fasting blood glucose concentrations between 5.60–6.09mmol/L and 6.10–
6.99mmol/L respectively (Sarwar et al., 2010).   
 
A similar result was observed in a systematic review of 18 observational studies 
investigating the relative risk of cardiovascular disease for both impaired fasting 
glucose and impaired glucose tolerance. Both impaired fasting glucose and impaired 
glucose tolerance were associated with a moderate increased risk for cardiovascular 
disease, with an overall relative risk ratio of 1.20 (95% CI 1.12–1.28) for impaired 
fasting glucose between 6.–6.9mmol/L (110–125mg/dL) and 1.18 (95% CI 1.18 
(1.09–1.28) for impaired fasting glucose of 5.6–6.9mmol/L (100–125mg/dL)  (Ford 
et al., 2010).  
 
2.4.2 Cognition and Memory 
 
One of the largest and most recent prospective studies; The English Longitudinal 
Study of Ageing (ELSA) demonstrated significant (p<0.001) cognitive decline (as 
assessed by immediate and delayed recall of ten dissimilar words) in participants 
with T2DM (n=446) and prediabetes (n=1190) compared with their 
normoglycaemic participants. Findings showed a 1 mmol/mol increase in HbA1c 




0.0001)), cognition (–0.0009 SD/year, (95% CI –0.0014, –0.0003)) and executive 
function (–0.0008SD/year, (95% CI –0.0013, –0.0004)) (Zheng et al., 2018). This 10-
year study with over 5000 participants highlights the potential effects T2DM has on 
cognitive function, but also the potential effects of being in the ‘vicinity’ of T2DM.  
 
In contrast, such associations on decline in cognitive function and prediabetes were 
not seen in the Maastricht study, which investigated the role of insulin resistance, 
hyperglycaemia and blood pressure in approximately 2,500 individuals with either 
normoglycaemia, T2DM or prediabetes (Geijselaers et al., 2017). Results indicated 
those participants with normoglycaemia as well as prediabetes performed similarly 
in tests of cognition, processing speed and executive function and attention, 
compared to those individuals with T2DM, who performed worse (Geijselaers et al., 
2017). 
 
2.4.3 Microvascular complications 
 
Microvascular complications in T2DM are common and typically present as; 
retinopathy, nephropathy or CAN (cardiac automatic neuropathy) (Dal Canto et al., 
2019). Diabetic retinopathy, which causes impaired vision and blindness, is the most 
common microvascular complication in T2DM, affecting approximately 100 million 
people globally (Leasher et al., 2016).  Diabetic nephropathy (DN) can be 
characterised on a continuum of increased urinary albumin output through to 
chronic kidney disease (CKD). DN results from poor glycaemic control as well as 
other risk factors; such as smoking, chronic hypertension, genetic disposition and 




microvascular complications (Dal Canto et al., 2019). CAN is a significant 
complication of diabetes mellitus (DM) defined by a deficiency in cardiovascular 
autonomic control resulting in an increased risk of cardiovascular mortality 
(Serhiyenko & Serhiyenko, 2018). Established risk factors for CAN in people with 
T2DM include suboptimal glycaemic control, dyslipidaemia, hypertension and 
obesity  (Serhiyenko & Serhiyenko, 2018). 
As the disease state of T2DM progresses, so does the prevalence rates for DN (Dal 
Canto et al., 2019). Findings from the UK Prospective Diabetes Study (UKPDS) 
showed an increased risk for death from a cardiovascular–related event with 
increasing degrees of diabetic nephropathy (Adler et al., 2003). T2DM can also 
induce a group of neuropathic disorders which affect both the autonomic and 
somatic nervous systems (Dal Canto et al., 2019). Diabetic neuropathy, known as 
diabetic peripheral neuropathy (DPN) can be broadly described as damage to 
multiple structures of the peripheral nerve and can involve autonomic, sensory as 
well as motor fibres depending on the cause of the clinical manifestation (Stino & 
Smith, 2017).  
 
In a recent longitudinal study, over 450 individuals were investigated for peripheral 
neuropathy via the use of a vibratory sensation instrument (MNSI – Michigan 
Neuropathy Screening Instrument) (Lee et al., 2015). Results illustrated the 
prevalence of neuropathy was highest (50%) in those individuals with recently 
diagnosed T2DM at the 3–year follow up period, followed closely by those 





2.5 Perceptions of risk in developing T2DM 
An individual’s perception of a disease risk can be more significant than the 
diagnosis itself, for in the perception, lies an individual’s ability to initiate disease 
risk-reduction behaviours (Troughton et al., 2008).  Many important psychological 
constructs already exist in an applied setting that have stressed this very idea – the 
seriousness with which an individual perceives their condition will directly impact 
their likelihood to engage in beneficial health-related behaviours (Troughton et al., 
2008).  
 
It has been well cited in the literature that the combination of diet therapy and 
physical activity resulting in modest weight loss can significantly reduce the risk of 
T2DM development in those who have knowledge of their prediabetes and even 
reverse prediabetes (Geiss et al., 2010).  Optimal management strategies for those 
at risk of T2DM include adherence to a healthy diet, stress reduction, physical 
activity and glucose monitoring/management, however it is thought that only a 
minority of patients actually achieve optimal management of their metabolic 
condition (Clinical Guidelines Taskforce (IDF), 2012). 
 
A cross-sectional analysis from the 2007/2008 and 2009/2010 National Health and 
Nutrition Survey (NHANES) identified a total of 2,964 participants who had 
prediabetes out of 10,539 eligible participants (Gopalan, Lorincz, Wirtalla, Marcus, 
& Long, 2015). Of those 2,964 participants, only 11.8% were aware they had the 




engagement in both physical activity levels as well as weight management strategies 
(AOR = 1.5 (95% CI 1.1 – 2.0)). Achievements in the Diabetes Prevention Programme 
(DPP) targets in prediabetes-aware participants was significantly higher than 
participants who were unaware (9.1% v 4.6%, P=0.02) (Gopalan et al., 2015). These 
results indicate having an awareness of prediabetes as well as receiving advice 
around risk, can modulate risk-reducing behaviours (Gopalan et al., 2015). However 
it is important to note that while prediabetes-aware subjects were more likely to 
engage in risk-reducing behaviours, overall, very few subjects actually reported 
reaching the DPP targets for physical activity (>150 minutes/week of moderate 
activity) and weight management (loss of 7% of body weight within the last year)  
(Gopalan et al., 2015). Exact reasons for this are not completely understood, 
although it is thought GP advice alone was insufficient to initiate and sustain risk-
reduction behaviours in order to meet DPP targets for physical activity and weight 
management in the majority of participants (Gopalan et al., 2015).  
 
2.5.1 Risk perception and actual risk  
 
A number of studies (Table 2.2) have shown differences between an individual’s 
perception of risk and their actual disease risk of T2DM (Heidemann et al., 2019; 
Hivert et al., 2009; Joiner et al., 2016; Kowall et al., 2017; Pinelli et al., 2009; Yang et 
al., 2018).  
 
Measurement tools used to assess actual and perceived risk of T2DM vary across 
studies, which make direct comparisons between studies (Table 2.2) difficult.  While 




of developing T2DM (Guess et al., 2015; Guo, Tang, et al., 2019; Hivert et al., 2009; 
Joiner et al., 2016; Pinelli et al., 2009; Shaak et al., 2018; Walker et al., 2003), other 
studies used self-designed questions to assess perceived risk (Claassen et al., 2011; 
Graham et al., 2006; Heidemann et al., 2019; Kowall et al., 2017; Maty & Tippens, 
2011; Yang et al., 2018).  
 
Similarly, measures of actual risk of T2DM development from studies (Table 2.2) 
have either been biomedical measures (such as OGTT or HbA1c) or differing 
variations of risk calculator tools (section 2.3.3.2), the most commonly used from 
the literature (Table 2.2) was the American Diabetes Association (ADA).  However, 
what has emerged as a common theme within the studies (Table 2.2) is an 
underestimation of actual risk based on an individual’s perceived risk.  
 
In the KORA FF4 study of 1,953 German individuals who completed a 
comprehensive health survey revealed individuals with undiagnosed T2DM and 
prediabetes significantly underestimated their risk of T2DM development in the 
future  (Kowall et al., 2017). Furthermore 72% (CI 95% 69–75) of individuals with 
prediabetes believed they had no risk of developing T2DM (Kowall et al., 2017).  
 
Similar findings were found in a cohort of 176 young mothers (mean age 31 years) 
with preschool aged children. Nearly 90% perceived their risk for developing T2DM 
to be slight or non-existent despite presenting with a family history of diabetes and 
as well as low levels of physical activity and fruit and vegetable intakes –  risk factors 




study highlight education and risk knowledge as potential focus points for reducing 
the disparity between perceived and actual risk.  
 
Similar findings were observed in a cohort of 120 prediabetic Hispanic adults who 
undertook a bi-lingual version of the RPS–DD survey (Shaak et al., 2018). Nearly 
77% of participants who undertook the survey reported knowledge of their 
diagnosis of prediabetes, yet diabetes risk knowledge was relatively low, with just 
over half of the diabetes risk knowledge questions answered correctly (5.59; SD = 








Table 2.2 Studies investigating perceived and actual risk of developing T2DM 




Measurement tools for actual and 
perceived risk 
Outcome 
      
      
      
(Claassen et al., 2011) Postal survey of 







255 Adults at increased 
risk for Diabetes & 
CVD (57–79yrs) 
Actual risk measure: 4 physiological risk factors 
(blood pressure, cholesterol, height & weight) and 3 
behavioural risk factors (eating habits, physical 
activity level and smoking status) 
Perceived risk measure: two 4–point scale 
questions: 
1. “How likely do you think it is that you will 
get diabetes within the next 10 years?” 
2. “Based on your feelings, what is the chance 
that you will develop diabetes within the 
next 10 years?” 
- Weak associations between risk factors and 
perceived risk of T2DM were found with 
self–reported risk factors contributing to 
11% of the variance in perceived risk of 
T2DM 
      




(based on ADA 






255 Volunteers who 
attended 
health/screening 





Actual risk measure: scoring a ‘yes’ or ‘no’ response 
to the ADA risk questionnaire 
Perception of risk measure: 34–question survey 
with 6 sections on; demographics, diabetes status, 
attitudes, risk assessment, access and glucose reading 
- 44% were at high risk for T2DM, 19% at 
low risk, 8% no risk and 29% did not 
respond to the ADA questionnaire. 
- 36% of participants who thought they were 
not at risk of developing T2DM had a high 
risk  










Actual risk measure: Diabetes UK risk assessment 
(scores: 0–6pts = low risk; 7–15pts = increased risk; 
16–24pts = moderate risk; 25+pts = high risk) + OGTT 
Perceived risk measure: RPS– DD (adapted slightly 
for a UK population)  
 
- 44% (26/59) had a high risk of developing 
T2DM, of this group, 34.6% perceived their 


















Mothers (mean age 




Actual risk measure: CHINARISK (Chinese version of 
the Canadian Diabetes Risk Assessment 
Questionnaire) 
Perceive risk measure: Question from the RPS–DD 
‘how do you perceive your risk of developing diabetes’ 
on a 4–point Likert scale from almost no risk to high 
risk  
 
- Approximately 90% of mothers had a low 
or slight perceived risk of developing T2DM, 
despite nearly 50% having risk factors for 
T2DM 
 
(Heidemann et al., 2019) Nation–wide 
German population 
survey  
2327 Adults (18–97yrs) 
without diagnosed 
diabetes 
Actual risk measure: German Diabetes Risk Score 
(GDRS) – calculates a 5yr probability of developing 
T2D 
Perceived risk measure: 4–point scale question: 
“What do you think is your risk for getting diabetes 
over the next 5 years?” 
 
- Across the four categories of actual risk: low 
(<2%), still low (2– <5%), elevated (5 – 
10%) and high (>10%), participant 
reported a perceived risk of 
89%,84.5%,79.3% and 78.9% respectively 








Survey for Diabetes 
Development (RPS 
–DD) + clinical 
markers of risk 
150 Non–diabetic primary 
care patients 
Actual risk measure: validated health record 
(unpublished) based on the following risk measures; 
anthropometry, resting blood pressure and fasting 
blood glucose 
Perceived risk measure: validated Risk Perception 
Survey for the Development of Diabetes (RPS–DD) 
- Patients with high perceived risk (34%) 
were more likely to have an actual 
increased risk of developing T2DM, 
however they were not more likely to adopt 
healthier lifestyle behaviours to decrease 
their risk (high 26% v low 29.2% P=0.69) 









Latinos attending local 
food–pantry 
distributions and 
health events/clinics in 
San Francisco Bay area 
(mean age = 39.2yrs 
+/–9.9yrs) 
 
Actual risk measure: ADA risk test (score ≥ 5 
indicates high risk) + A1C (3 categories: <5.7%; 5.7% – 
6.5%; ≥6.5%) 
Perceived risk measure:  Spanish language 
translation of the RPS–DD (42 items with 6 measures; 
Personal Disease Risk scale, Environmental Health 
Risk scale, Personal Control subscale, Optimistic Bias 
subscale, Worry subscale, and Diabetes Risk 
Knowledge test) 
 
- 69% had a low perceived risk of developing 
T2DM, of this group 20% had an ADA risk 
score ≥5 and 11% had an A1c result 
consistent with prediabetes  
 







Women with a history 
of Gestational diabetes 
mellitus (GDM) 
 
Actual risk measure: history of GDM 
 
Perceived risk measure: 4–point Likert scale 
question: “What do you think your risk or change is for 
getting diabetes over the next 10 years?’’ Answers 
included ‘’almost no chance’’, ‘’slight chance’’, 
‘’moderate chance’’ and ‘’high chance’’ 
 
- 90% reported GDM as a risk factor for 
future T2DM development, but only 16% 
believed they had a high chance of 
developing T2DM 
- Women who perceived their risk to be 
moderate or high reported they were more 
likely to modify future lifestyle behaviour 






(Kowall et al., 2017) Population–based 
KORA FF4 Study 
1953 Adults (mean 59.1yrs) 
without known 
diabetes  
Actual risk measure:  Oral Glucose Tolerance Test 
(OGTT) 
Perceived risk measure: three questions asked about 
risk perception 
1. How do you estimate your risk currently? 
2. Do you believe you are at risk in the future? 
3. How serious do you think T2D is in your 
view? 
 
- 72% (95% CI 69–75) of participants with 
prediabetes believed they were not at risk 
of developing T2DM.  
 
- 74% (95% CI 65–82) of participants with 
UDM believed they had low or very low risk 
of developing T2DM  
(Maty & Tippens, 2011) Cross–sectional 
survey 
324 Chinese & 
Hispanic/Latino 
Adults (mean age = 
45.2yrs) 
Actual risk measure: based on self–reported risk 
factors as determined by the American Diabetes 
Association (ADA) guidelines 
Perceived risk measure: Perceived diabetes risk was 
determined from the question: ‘If you do not have 
diabetes, do you think you are at risk for developing 
diabetes?’ Response options were: ‘yes’, ‘no’ and ‘I don’t 
know’.  
  
- 43% of participants had a high risk of 
developing TDM (based on having two or 
more ADA risk factors) 
 
- 24.6% reported no perceived risk and 
52.7% were unaware of their risk 
(Pinelli et al., 2009) Cross–sectional 
study: RPS–DD 




218 Pharmacists (46.2yrs 
+/–12.2yrs) 
Actual risk measure: ADA risk test (score of 3–9 = 
low risk and a score of 10+ = high risk) 
Perceived risk measure: RPS–DD 
- According to the ADA results, 36% of 
pharmacists had a higher risk of developing 
T2DM  
- Significant differences between ADA risk 
(low v high) status and Comparative 
Disease risk such that: low 1.93±0.42 v high 
2.08±0.42, P=0.02). Overall, there was slight 
to moderate perceived risk of developing 
T2DM (2.25±0.90) 
 






120 Registry of electronic 
records from a multi–






Actual risk measure: ICD–10 diagnosis code 
(impaired fasting glucose/HbA1c reflecting 
prediabetes) 
 
Perceived risk measure: RPS–DD 
 
- Low knowledge of T2DM risk (mean score 
from Diabetes Risk Knowledge test = 5.59 
(out of a possible 11) SD (1.65) despite 77% 
of participants reported being told they had 
prediabetes  
-  
(Walker et al., 2003) 
 
Cross–sectional 






workshops in the USA 
(mean age = 48.9yrs 
+/– 9.8yrs 
Actual risk measure: ADA risk test  
Perceived risk measure: RPS–DD 
 
- 196 physicians had a high risk of 
developing T2DM based on self–reported 
ADA risk test 
- 50% of them reported an optimistic bias 
that they were less likely to get T2DM 





(Yang et al., 2018) Sample from the 
2011–2014 





9496 Adults (<20yrs) Actual risk measure: American Diabetes Association 
Guidelines 
Perceived risk measure: closed–ended question: ‘’Do 
you feel you could be at risk for diabetes or 
prediabetes?” 
- 28.4%(n=2696) indicated a high perceived 
risk for T2DM development.  
 
- Of the 2696, 38.3% (n=1032) had an actual 







2.5.2 Barriers and risk perception 
 
Certain factors can act as barriers, reducing an individual’s ability to initiate 
behaviour change strategies to reduce T2DM risk. Barriers can be environmental 
such as the ease to which individuals can access parks or gyms to exercise. The 
design of roadings, and the opportunity for cycle-lanes and walkways can also act as 
barriers if not designed well.  Barriers can also be financial such as the affordability 
of healthy food, doctor’s visits, and gym memberships.  Lack of time due to family 
and work responsibilities can also be a barrier (Winett et al., 2015) as well as 
mistrust of health professional advice (Lawrence, Nathan Reynolds, & Joseph Venn, 
2017)  An individual’s  lack of awareness of their disease risk can also be a barrier 
(Gopalan et al., 2015). 
 
The ‘Resist–Diabetes study’ performed by Winett and colleagues (2014) 
investigated the effectiveness of a theory-based maintenance approach by differing 
doses of resistance training (RT) in an aim to analyse if a higher-dose social cognitive 
theory (SCT) approach would produce greater RT adherence than a lower-dose 
standard treatment in 170 men and women with prediabetes. The study spanned 
over 15 months and showed very little difference between high or low-dose 
treatment approaches with both treatment groups reporting barriers for not 
completing RT sessions.  
 
For the SCT group, barriers included travel for work or vacation (22.3 %), busy 
schedule and typical family responsibilities (21.71 %), and minor health-related 




financial costs were minimal (12.4 %). The standard group reported  similar results; 
travel (18.9 %), busy schedule and family responsibilities (20.0 %), minor health 
issues (30.5 %), and only minimal reporting for health club issues.  (8.7 %) (Winett 
et al., 2015). 
 
Whilst this study did provide some insights into potential barriers faced by people 
with prediabetes who implemented lifestyle changes, it failed to report on other 
potential significant findings such as weight change, reduction in diagnostic 
parameters (such as those defining IGT or IFG) which would have given a deeper 
insight into the effectiveness of each of the treatment arms. Furthermore the 
perceived barriers reported in this study were confined to resistance training only, 
which is just one facet of lifestyle change that could be perceived as a barrier to 
change in people with prediabetes, thus further studies are needed to explore all 
facets of lifestyle change that could be perceived as potential barriers to change. 
 
In a more extensive study, researchers conducted semi-structured qualitative 
interviews with 35 prediabetic participants to explore patient knowledge around 
the risk of developing diabetes now and in the future, as well as perspectives on 
treatment options available (O'Brien et al., 2016). Results from the interviews 
suggested there are gaps in knowledge around the risk of T2DM and treatment 
options available, however when participants were presented with the evidence and 
options, they felt motivated that prediabetes had optimistic outcomes and felt that 
a diagnosis of prediabetes was not a ‘given’ for diabetes progression to T2DM 
(O'Brien et al., 2016). For example, many participants had overestimated the risk of 




were told the risk of development to T2DM was lower than they actually thought 
(O'Brien et al., 2016). Additionally when participants were told about the reduction 
in risk of T2DM development with the use of metformin as well as intensive lifestyle 
interventions, they felt motivated to take control of their prediabetes, with the 
knowledge of solutions and management options available to them (O'Brien et al., 
2016). 
 
A recent pilot study investigating healthy food perceptions in people with both 
T2DM and prediabetes via focus group discussions illustrated participants were 
distrusting of professional nutrition advice due to the inconsistencies in information 
given. This acted as a barrier for participants to trust in the advice given to initiate 
change (Lawrence et al., 2017). Furthermore, the study also highlighted 
participant’s nutritional knowledge varied between participants and was at times 
contradictory to national nutritional guidelines (Lawrence et al., 2017). Lack of 
nutritional knowledge as a barrier to diabetes management was also seen in a study 
conducted in rural Kentucky with 71 participants with self–reported T2DM in an 
aim to investigate challenges rural residents of Kentucky face in diabetes self-
management (Ashrafzadeh, Tohidi, & Nasseh, 2017). The study highlighted those 
participants who perceived diet to play an important role in diabetes management 
(blood sugar control) showed more interest in attending cooking classes. This 
perception was a stronger determinant of cooking class interest above other 
important factors of blood sugar control including exercise, medication compliance 
and glucose monitoring. This result suggests understanding participants 
perceptions and beliefs on a personal level could help inform and develop a more 




study was the small participant numbers (n=12), with only two participants 
diagnosed with prediabetes. (Lawrence et al., 2017).  
 
Whilst Lawrence et al (2017) offered some interesting insights into what 
participant’s perceived as ‘healthy’, this research was limited in its focus, 
concentrating only on healthy food perceptions with respect to; perceptions of 
dietary information, food components and factors that are perceived to influence 
the healthfulness of foods (Lawrence, et al. 2017). The study did mention there was 
a gap in the literature to investigate beliefs and perceptions of subjects at an earlier 
stage of the disease (ie at the prediabetic stage, or early diagnosis of T2DM).  
 
2.6 Prevention strategies 
Prevention is amongst one of the most powerful public health approaches that can 
achieve a reduction in T2DM (Shawley-Brzoska & Misra, 2018). Preventative 
prescriptions for a reduction in T2DM incidence are centred around lifestyle 
modification (changes in diet and exercise) with or without the use of 
pharmacological agents, (Coppell et al., 2010; Fogelholm et al., 2017; Knowler et al., 
2002; Lean et al., 2018; Shawley-Brzoska & Misra, 2018; Tuomilehto et al., 2001).  
Multiple dietary approaches have been investigated in the management of T2DM, 
including reduced calorie diets, low carbohydrate diets, the Mediterranean Diet 
(MD) as well as low GI diets (Fogelholm et al., 2017; Georgoulis, Kontogianni, & 
Yiannakouris, 2014; Krebs et al., 2013; Zafar et al., 2019). 
 
A recent systematic review and meta-analysis of studies including more than 




between those participants who consumed a plant-based diet compared with those 
who did not, and risk for developing T2DM (RR, 0.77; 95% CI, 0.71–0.84) (Qian, Liu, 
Hu, Bhupathiraju, & Sun, 2019). However, despite individual’s being armed with 
nutrition and exercise knowledge to initiate behaviour change and lifestyle 
modification, these lifestyle strategies fail to accommodate an individual’s 
perceptions and beliefs, not just about their condition, but them as individuals as 
well, coupled with the fact that behaviours learnt over a lifetime are not easily 
unlearnt or changed. For example many individuals know what healthy food is, and 
that exercise is important for healthy outcomes to reduce the risk of T2DM, but such 
compartmental knowledge of nutrition and lifestyle strategies can often be blurred 
by levels of self-efficacy, motivation and personal beliefs, especially during busy 
daily routines that generate stress, anxiety and every-day challenges.  
 
In one of the largest international randomised control trials (PREVIEW) to date, 
2,326 (including 321 from New Zealand) overweight prediabetic participants were 
recruited to investigate the most effective lifestyle pattern for reducing the risk of 
T2DM development (Fogelholm et al., 2017).  What made this study unique was that 
it recruited participants first, into an intensive 8-week weight loss programme 
(Cambridge weight loss programme) (phase I) via the use of daily meal 
replacements totalling 800 calories/day.  The goal was for participants to achieve a 
reduction of at least 8% of their baseline body weight first, before becoming eligible 
for the randomisation phase (phase II). There were 1,854 participants who achieved 
this, with 35% returning to normoglycaemic levels at the end of the 8-week period 





These participants were then recruited into a 3-year randomised weight 
maintenance phase which included eight treatment arms of; diet (high protein/low 
GI diet versus traditional best practice moderate protein/higher carbohydrate 
moderate GI diet), exercise (75 minutes high intensity v 150 minutes/moderate 
intensity) and behaviour change support.  
 
Results from the 3-year study found an incident rate for T2DM to be just 4%. This is 
an impressive result. Even the researchers were expecting a higher (13%) incidence 
rate (Sydney Ideas, 2019). However, it is worth noting the trial had a relatively large 
dropout rate, with just under 950 participants completing the study. There were 
also similarities in treatment groups with regards to urinary nitrate outputs 
suggesting non-adherence to differing protein intakes between the treatment 
groups.  The challenge now remains in how to translate these study-based successes 
into real-life clinical practice.  
 
A similar, but smaller randomised study called the Diabetes Remission Clinical Trial 
(DiRECT) was carried out in the UK, involving 49 different primary care practices 
with 306 participants who were overweight and had had T2DM for at least 6 years 
(Lean et al., 2018).  Participants were randomised to either receive routine care or 
weight management programme ((involving a total diet replacement of approx. 850 
calories/day for 3-5 months), a food-reintroduction phase and then a weight-
maintenance programme). Results from the study showed statistically significant 
differences for weight loss of 15kg+ (26% in the treatment group v 0% of 
participants in the control arm, P<0.0001) as well as T2DM remission (defined by 




participants in the control arm, P<0.0001). What was different between the DiRECT 
trial compared with the PREVIEW trial was that this study was done in the context 
of a primary care setting, proving study findings can be translated into a real-life 
clinical setting.  
 
In contrast to the PREVIEW and DiRECT trials, The Diabetes Prevention Programme 
(DPP) study investigated a lifestyle intervention (7% BW loss + 150mins/week of 
exercise) and compared it against the pharmacological ‘go-to’ drug for managing 
glucose control in T2DM patients – Metformin (Diabetes Prevention Program 
Research Group, 2002). Lifestyle coaches and behavioural strategies were made 
available to participants in the lifestyle intervention group.  Results from the 3,234 
overweight participants with prediabetes found the lifestyle intervention reduced 
the incidence of diabetes by 58% and by 31% in the Metformin group compared 
with control in an approximate 3-year follow–up period, suggesting lifestyle 
intervention is more effective at managing glucose control that Metformin.  
 
Another largescale study which has explored lifestyle modification in an attempt to 
reduce T2DM risk is The Finnish Diabetes Prevention Study (DPS) (Lindstrom et al., 
2003). In this randomised control trial 522 overweight adults with impaired glucose 
tolerance (IGT) were divided into a control group (standard care) and a treatment 
group (lifestyle intervention of resistance exercises and dietary advice). Results 
from one and three year follow-ups showed significantly greater weight-loss in the 
intervention group compared to the control, with 3.5kg and 2.6kg differences 





A review by Hall and colleagues (2016) investigated different macronutrient 
compositions in the diet and the effect this had on T2DM management outcomes. 
The authors examined the evidence for weight loss and glycaemic control in; very 
low carbohydrate diets (VLCDs), lower carbohydrate, higher protein (LC/HP) diets 
and low carbohydrate paleolithic–type diets. The role of macronutrient 
manipulation in the form of VLCD’s (typically <50g CHO/day) showed initial success 
in weight loss and glycaemic control, although they reported a lack of consistency in 
results with limited evidence for long-term benefits in either HbA1c levels or 
sustained weight loss (Hall, Strong, & Krebs, 2016).  
 
Hall and colleagues (2016) also reported a systematic review of 13 randomised 
controlled trials investigating low carbohydrate/high protein diets compared with 
low fat/high carbohydrate diets (Hession, Rolland, Kulkarni, Wise, & Broom, 2009). 
Results from the 13 RCTs, which ranged in duration from 6 – 36 months found low 
carbohydrate diets were more effective in reducing weight at 6 months and up to 
one year, compared with low fat/high carbohydrate diets. Although they note, there 
were only a small number of studies which included participants with diabetes. A 
year after Hall and colleagues (2016) published their review, a meta-analysis of nine 
randomised controlled trials with 734 T2DM patients reported a significant 
decrease in HbA1c levels in the low carbohydrate diet (LCD) group compared with 
the control ((weighted mean difference (WMD): –0.44, 95% CI: –0.61,–0.26), 
P=0.00)) (Meng et al., 2017). No significant WMD were observed for weight loss 





While Hall and colleagues (2016) state dietary composition should underpin the tri–
dimensional foundation for optimal T2DM management via improved glycaemic 
control, optimal weight management (through weight loss or maintenance) and 
reducing the risk of microvascular and macrovascular complications, what appears 
to be most important in optimal T2DM management, irrespective of carbohydrate 
type or amount, is that it can be maintained long–term (Hall et al., 2016). 
Furthermore, Hall and colleagues (2016) note the complex nature of gene–
environment interactions and the need for further investigation into the role they 
play in individualisation of diet prescriptions (Hall et al., 2016).  
 
The Mediterranean diet was first coined by Ancel Keys, who established the link 
between saturated fat and CVD. In more recent years research has established 
support for the link between a Mediterranean-style diet and its’ protective 
mechanisms against T2DM (Georgoulis et al., 2014). A recent systematic review 
which included 8 meta-analyses and 5 RCTs showed the Mediterranean diet was 
more effective at improving glycaemic control and risk factors for CVD (including a 
reduction in body weight, reduced total cholesterol and high-density lipoprotein 
cholesterol) compared with control diets and diets lower in fat (Esposito et al., 
2015). 
 
While most research in the field of T2DM prevention have focused on lifestyle 
change (diet and exercise), a recent New Zealand based study of 14,043 primary 
care patients with prediabetes from the Upper North Island region demonstrated 
the use of native language was a protective factor in reducing progression of 




thirds lower progression rates to T2DM in those participants who spoke Te Reo 
Māori (RR 0.31 CI: 0.12 –0.81).  This finding is important, given the greater 
progression rates and incidence of T2DM in Māori and Pacific Peoples, compared to 
their NZ European peers (Teng et al., 2019). 
 
The amount of research examining prevention strategies and their impact in 
improving glycaemic control and reducing progression of prediabetes to T2DM can 
only be strengthened with understanding an individuals’ perception of their risk 
and comparing it to their actual risk of developing T2DM. This will offer insights into 
barriers of understanding risk. The current study will address an individual’s 
perceived risk and compare it to their actual risk of developing T2DM in a sample of 















Chapter Three – Method  
 
The purpose of this chapter is to provide details of the methods used to carry out 
the research project. Section 3.1 describes the ethical approval process of the study 
and section 3.2 discusses the participants, including screening (inclusion/exclusion 
criteria) and sample size. Section 3.3 describes the survey design, the questionnaire 
platform used as well as details of the three sections of the online questionnaire 
which include; general health and demographics section; perceived risk of T2DM 
section (as measured by the RPS–DD) and actual risk of T2DM section (as measured 
by the Diabetes New Zealand ‘Are you at risk?’ calculator.  Section 3.4 describes the 
statistical analysis carried out based on both participant’s perceived risk and actual 
risk status.  
 
3.1 Ethical approval process 
 
The research project was approved by the Massey University Human Ethics 
Committee:  Human Ethics Northern Committee (Application NOR 19/13). All 
participants were informed of the study benefits and risks as well as what was 
required of them in taking part in the questionnaire via the participant information 
sheet (Appendix 1). The questionnaire was anonymous. All data collected from the 
questionnaire was stored electronically via the password protected Massey account 
of Qualtrics. This data was then analysed via the password protected Massey 






3.2 Participants  
 
Participants were men and non-pregnant women, over the age of 18 years without 
a diagnosis of diabetes and who were New Zealand residents or citizens.  
3.2.1 Recruitment process 
 
The main avenue for recruiting participants was via the School of Sport, Exercise & 
Nutrition research participant database at Massey University, Albany. The database 
collects contact information from previous research participants (who provide their 
permission and declared interest in being contacted about future research projects). 
The study was also advertised to employees at the New Zealand Heart Foundation 
(n=95) via their internal communication channel Yammer. The study was also 
advertised in the Massey University e–newsletter.  
 
An email (Appendix 2) advertising the study, along with the participant information 
sheet (Appendix 1) and a link to the questionnaire (Appendix 3) was sent to the 
School of Sport, Exercise & Nutrition research participant database (n=960). 
Participants who clicked on the link to the questionnaire were first screened for 
eligibility by answering four eligibility questions based on the inclusion/exclusion 
criteria (section 3.2.2). Eligible participants, who satisfied all four screening 
questions were then directed to the questionnaire. 
 








Before participants were directed to the online questionnaire they were asked four 
eligibility questions (Appendix 3) based on the below inclusion and exclusion 
criteria such that participants; had to be a New Zealand citizen or resident, over the 
age of 18 years, non–pregnant and not have a diagnosis of diabetes (type 1 or type 
2 diabetes mellitus).  
 
3.2.2.1 Inclusion criteria 
 
The terms ‘’New Zealand citizen or resident’’ were chosen as the method of 
determining a New Zealand population, given this was the primary population 
under investigation in this study.  
 
Adults over the age of 18 years were chosen as the risk of developing T2DM  
increases with age, with prevalence rates of both prediabetes and T2DM more 
significantly represented in an adult population (although it is noted incidence rates 
are increasing in childhood).  
 
The questionnaire was only available in electronic format, therefore participants 








3.2.2.2 Exclusion criteria  
 
Women who were pregnant were excluded due to the potential for bias towards 
perceived risk around developing T2DM. Additionally, fluctuations in weight could 
potentially impact on the actual risk score of developing T2DM, which would not be 
a true reflection of actual risk. 
 
People who had a diagnosis of type 1 diabetes mellitus or  type 2 diabetes mellitus 
were excluded due to the bias this would cause to their perceived risk of developing 
T2DM.  
 
3.2.3 Sample size 
 
Based on previous studies (Table 2.2) which have investigated perceived risk versus 
actual risk of developing T2DM, participant numbers have ranged from 59 (Guess et 
al 2015) to 9,496 (Yang et al., 2018). For these studies there has been no specific 
justification for sample size or power of these studies given to be able to determine 
a sample size. Nine of the 14 studies (64%) shown in Table 2.2 had a sample size 
ranging from 120–350 participants. This sample size range was the basis for 
recruitment numbers in the present study which also examined perceived vs actual 
risk of T2DM development (Claassen et al., 2011; Graham et al., 2006; Guo, Tang, et 
al., 2019; Hivert et al., 2009; Joiner et al., 2016; Kim et al., 2007; Maty & Tippens, 






3.3 Study Design 
 
This study is an observational cross-sectional design due to the observational nature 
of the data (characteristics and frequencies) collected with no assigned exposures 
to participants in investigating perceptions and actual risk of developing T2DM 





The questionnaire (Appendix 3) was designed in the platform Qualtrics, via the 
secure Massey University Qualtrics account. The questionnaire was only available 
in electronic format for participants to complete. Eligible participants were directed 
to answer all three sections of the online questionnaire, which took approximately 
10 minutes to complete.  
 
Section one of the questionnaire consisted of twelve general health and 
demographic questions (section 3.3.1.1). Section two consisted of questions from 
the validated Risk Perception Survey of Diabetes Development (RPS–DD) (Walker 
et al., 2003) (Revised 2009 ©E.A Walker 2009) as well as three questions on risk 
perception and lifestyle modification (RPLM–DD) from Kim et al (2007) (section 
3.3.1.2). Section three consisted of questions from the Diabetes New Zealand ‘Are 
you at risk?’ calculator (section 3.3.1.3). At the end of section three, participants 
were provided with their actual risk score of developing T2DM and information 





3.3.1.1 Section one: General health and demographic questions 
 
Section one of the questionnaire consisted of 12 questions on: age, weight, height, 
ethnicity, education level, suburb and city of residence, employment, previous 
medical history as well as questions regarding visits and experiences of risk 
communication and CVD/T2DM tests recommended by their healthcare provider. 
BMI was calculated in SPSS based on weight and height information obtained from 
section one of the questionnaire.  
 
3.3.1.2 Section two: Perceived risk of T2DM development  
 
Section two of the questionnaire included the validated Risk Perception Survey for 
Developing Diabetes (RPS–DD) (Walker et al., 2003) (Revised 2009 ©E.A Walker 
2009) , which has been reported in previous literature (Guess et al., 2015; Hivert et 
al., 2009; Joiner et al., 2016; Shaak et al., 2018; Walker et al., 2003) and assesses 
various dimensions of perceived risk for developing T2DM. Section two of the 
questionnaire also included three questions on risk perception and lifestyle 
modification in developing diabetes (RPLM–DD) based on previous literature by 
Kim et al (2007).  
 
Section two consisted of eight questions with four main subscales assessing; general 
attitudes towards risk including Personal Control, Optimistic Bias, Comparative 
Disease risk and Comparative Environmental risk as well as questions around 
diabetes knowledge of risk factors that could increase the risk of developing T2DM 





The Optimistic Bias subscale assessed a participant’s belief in their risk on a scale 
from 1 (less bias) to 4 (more bias) of developing diabetes compared with others of 
similar age and gender. 
 
The Personal Control subscale assessed a participant’s belief in their self-control 
over developing diabetes. A 4-point scale from 1 (strongly agree) to 4 (strongly 
disagree) was used with a higher score indicating greater perception of control.  
The Comparative Disease risk subscale assessed a participant’s belief in their 
perceived risk of developing 14 common diseases or disorders, compared with 
diabetes. A 4-point scale from 1 (almost no risk) to 4 (high risk) was used, with a 
higher reported score indicating a greater perceived risk.  
 
The Comparative Environmental subscale assessed a participant’s belief in their 
perceived risk of being exposed to nine environmental hazards such as exposure to 
household chemicals, medical x–rays and air pollution. A 4-point scale from 1 
(almost no risk) to 4 (high risk) was used, with a higher reported score indicating a 
greater perceived risk.  
 
Questions on Diabetes Risk Knowledge were also included which asked participants 
to rate risk on a 4-point scale, such that; 1 (increases the risk), 2 (has no effect), 3 
(decreases the risk) and 4 (don’t know) on the impact diabetes risk factors such as 
age, ethnicity, diet, exercise and family history of diabetes, have on the development 





The last three questions of section two asked participants about their risk 
perception and lifestyle modification (diet and exercise) with respect to developing 
T2DM. The first of these questions asked participant’s opinions on lifestyle 
modification (diet and exercise)and if it could prevent T2DM. Responses were on a 
5-point Likert scale from strongly agree to strongly disagree. The next question 
asked participants what their 10-year risk of developing T2DM was on a 4-point 
Likert scale from almost no change to high chance. Participants were also asked if 
they had any plans to modify lifestyle factors (diet and exercise) to lower their risk 
of developing T2DM. This required a ‘yes’ or ‘no’ response.  
 
Participants were stratified into ‘low perceived diabetes risk’ and ‘high perceived 
diabetes risk’’ based on the Comparative Disease risk question of developing 
diabetes compared to other diseases.  Participants who answered ‘almost no risk’ or 
‘slight risk’ were classified as having a low perceived diabetes risk and participants 
who answered ‘moderate risk’ or ‘high risk’ were classified as having a high 
perceived diabetes risk. This method of obtaining a low and high perceived risk 
measure has been done in previous literature (Guo, Tang, et al., 2019; Hivert et al., 
2009; Joiner et al., 2016) 
 
3.3.1.3 Section three: Actual risk of T2DM development  
 
This section of the questionnaire was based on eight questions relating to the 
participant’s actual risk of developing diabetes. Questions in this section were based 
on the Diabetes New Zealand website risk calculator ‘Are you at risk?’ (Appendix 4).  




participant–blinded numeric score attached, which contributed to the overall actual 
risk score that the participant viewed at the end of section three in the 
questionnaire.   
 
Three questions from the Diabetes ‘Are you at risk?’ calculator was slightly modified 
to reduce the ‘perception factor’ in the question. The first question that was slightly 
modified was: ‘’I am overweight for my height’’ (Appendix 3) which was modified to: 
‘’Is your BMI (body mass index) over 25? To work out your BMI, please click here” 
(Appendix 3). The second question that was slightly modified was to add a quantifier 
to the question ‘’I do very little physical activity’’ (Appendix 3), so that it read; ‘’I do 
very little physical activity (ie less than 2.5 hours per week)’’ (Appendix 3). The third 
question that was slightly modified also had a quantifier added to the question, such 
that ‘’I often eat foods high in fat and sugar’’ (Appendix 3) became ‘’ I often (ie most 
days of the week) eat foods that are high in fat and sugar?’’ (Appendix 3).  
 
Based on the Diabetes New Zealand ‘Are you at risk?’ calculator, actual risk of 
developing diabetes was stratified into two risk groups; low risk (a score of between 
3–5) and increased risk (a score greater than 5). The risk stratification was based 
directly on the Diabetes New Zealand ‘’Are you at risk?’’ risk scoring criteria.  
 
Participants who had a score between 3 – 5 were told they had a low risk of 
developing T2DM now, but they may have an increased risk in the future. 
Participants who had a score between 3 – 5 were categorised in the study as having 




Participants who had a score greater than 5 were told they had an increased risk of 
developing T2DM now, however only a doctor could diagnose T2DM. Participants 
were directed to contact or visit their GP for more information. Participants who had 
a score greater than 5 were categorised in the study as having an ‘increased risk’ of 
developing T2DM.  
Additional information about the participant’s risk score was included at the end of 
the questionnaire, which has been sourced directly from the Diabetes New Zealand 
website (Appendix 3 & 4). The information about a participant’s risk score could be 
viewed at the same time as viewing their risk score.  
 
3.4 Statistical analysis  
 
The IBM Statistical Software Package (SPSS) version 26 was used to analyse the data. A 
P value of less than 0.05 was considered a statistically significant result. Due to the nature 
of the data set (outliers, zero scores, and significant categorical data) normalisation was 
not an option, hence non-parametric tests were used for analysis of the results.  
 
 
3.4.1 Demographic characteristics  
 
The Mann-Whitney and Chi-squares tests were used to determine significant 
differences in demographic characteristics of the participants, stratified by low and 
high perceived risk status. Effect size was reported for significant P–values (P<0.05). 






Analysis for differences in ethnicity was not possible in the current study as the 
majority (88% (225/257)) of participants recruited were of New Zealand European 
ethnicity. Only 1% of participants identified as Màori and no participants identified 
as being of Pacific peoples. Given both prediabetes and T2DM in New Zealand is 
overrepresented in ethnicities such as Màori and Pacific peoples, 
underrepresentation of these ethnicities is the most significant limitation of this 
study. This limitation is discussed further under section 5.3.2.  
3.4.2 Perceived risk versus actual risk  
 
The Wilcoxon Signed Ranks test was used to determine differences between 
participant’s actual risk (low and increased risk) of developing diabetes and their 
perceived risk (low and high risk) of developing diabetes. Effect size (r) was 
reported for significant values of P.  Further analysis using the Wilcoxon Signed 
Ranks test was also carried out for the RPS–DD question regarding what 
participants perceive their 10–year risk of developing diabetes to be. This variable 
was recoded to generate a ‘low’ and ‘high’ perceived 10–year risk. Effect size (r) was 
reported for significant values of P.   
 
Participants perceived risk score was presented on a Likert scale such that 
participants who answered ‘almost no risk’ or ‘slight risk’ to the Comparative 
Disease risk question of developing diabetes compared to other diseases (Appendix 
3) were given a ‘low risk’ classification. Participant’s actual risk score, based on the 
Diabetes New Zealand ‘Are you at risk?’ calculator (Appendix 4) was represented as 





3.4.3 Analysis of the Risk Perception Survey of Developing Diabetes (RPS–DD) 
 
3.4.3.1 Reliability analysis of the RPS–DD 
 
Cronbach’s α were determined for the five scales of the RPS–DD: Personal Control, 
Optimistic Bias, Risk Knowledge, Comparative Disease Risk and Environmental 
Disease risk.  Two subscales for Personal Control as well as both subscales for 
Optimistic Bias were reverse scored due to the reserve-phrasing of these subscales. 
The reverse-phrasing was to reduce response bias to the questions.  
 
A Cronbach’s α is a measure of internal consistency, or how closely related two 
variables are. A Cronbach’s  α  of 0.80 or greater is considered a good measure of 
reliability and consistency of the questionnaire (Field, 2009). 
 
Reliability analysis of the five scales were stratified by actual and perceived risk 
status. Values are represented as medians (25th, 75th percentiles).   
 
3.4.3.2 RPS–DD Diabetes Risk Knowledge  
 
The Diabetes Risk Knowledge section of the RPS-DD consisted of ten questions 
which were recoded into new variables in order to obtain a binary ‘correct’ (one 
response per question) or ‘incorrect’ (for all other responses). All correct responses 
were summed for each of the ten questions. Pearson’s Chi square analysis was 
carried out to analyse differences in knowledge between low and high perceived risk 




Square had been violated. Effect size (Phi) was given for significant P-values. 
Diabetes knowledge values are represented as number and percentage of correct 
answers.  
 
3.4.4 Gender analysis  
 
The data was stratified by gender to see if there was a significant difference between 
gender and the frequency of GP visits, GP communication of diabetes risk and GP-
recommended tests of diabetes and CVD, perceived risk, actual risk, prediabetes 
diagnosis, education level and RPS-DD Diabetes Risk Knowledge scores. The data 
are non-normally distributed, so the Pearson’s chi-square test was used. Data were 
cleaned for missing values and to meet assumptions of the test. Significant 
differences are recorded at P-value <0.05. Effect size (Cramer’s V) are reported for 
significant values of P.  Values reported are presented as total numbers and 
percentages.  
 
3.4.5 GP Communication and risk 
 
Pearson Chi-square analysis was carried out to determine if there was a significant 
difference between actual risk status (low vs increased) and GP communication 
about diabetes/CVD risk and frequency of GP visits as per the questions asked in 
section one of the questionnaire (Appendix 3). Significant differences are reported 
at P<0.05.  Values are reported as numbers and percentages.  Spearman’s 
correlations (Rho(s)) were also conducted to ascertain any associations between 





3.4.6 Identifying factors that influence perceived risk 
 
3.4.6.1 Spearman’s correlation analysis  
 
Spearman’s correlation (Rho(s)) analysis was conducted to understand possible 
variables that correlated with perceived risk status. Statistically significant 
correlations were determined at P<0.05. Variables that were included in the 
Spearman’s correlation analysis included; gender, education level, age, the five 
subscales from the RPS–DD, frequency of GP visits, GP-recommended tests for 
T2DM/CVD, GP communication about T2DM/CVD risk, risk factors for T2DM, RPS-
DD beliefs on health and diabetes.  
 
3.4.6.2 Binary logistic regression analysis  
 
Binary logistic regression analysis was conducted to determine the variables that 
could potentially predict perceived risk of developing T2DM. Beta values, standard 
error, odds ratio (exp(B)) and 95% confidence intervals (CI) are reported. 
Nagelkerke R2 is also reported to explain the variation of the dependent variable 
(perceived risk) based on the predictor variables included in the model.  Variables 









Chapter Four – Results 
 
The purpose of chapter four is to describe the findings of this research project. 
Section 4.1 provides information on the participants involved in this study. Section 
4.2 describes the findings between participant’s perceived risk compared to their 
actual risk status. Section 4.3 reports on the analysis of the RPS–DD including, 
reliability of the questionnaire, diabetes knowledge and motivation. Section 4.4 
focuses on GP–related variables and the relationship this has with actual risk status. 







A variety of methods were used to recruit participants for this study (section 3.2.1). 
Data collection took place between July 2019 until October 2019. Two hundred and 
ninety-three participants answered the initial screening questionnaire. After 
screening, 266 participants were eligible and completed the questionnaire. Nine 
participants were excluded due to due to missing data resulting in an inability to 
compute a risk score, resulting in 257 participant data that were included in the 
main analysis. Where analysis has been made due to missing data for other specific 






4.1.2 Demographic characteristics 
 
Of the 257 participants, 68% (175/257) were female, 31% (80/257) were male and 
0.8% (2/257) participants did not specify male or female.  Ninety-one percent 
(235/257) of participants were from the Auckland region of New Zealand. Three 
percent (8/257) were from the Northland region. Two percent (4/257) were from 
the Wellington region. One percent (3/257) were from the Waikato region. Less 
than one percent were from the Canterbury region (2/257), Taranaki region 
(1/257), Manawatu region (1/257), Bay of Plenty region (1/257) and West Coast 
region (1/257) and one participant was currently residing in London but was a New 
Zealand citizen or resident.  
 
Demographic characteristics (Table 4.1) of participants were stratified by their 
perceived risk for developing T2DM which was either a low perceived risk or a high 
perceived risk, based on the RPS-DD question ‘What do you think your risk of 
developing diabetes is?’ (Appendix 3).  
 
Participants with a low perception of T2DM risk were 86% (220/257) and 14% 
(37/257) had a high perception of T2DM risk (Table 4.1).  There were no statistically 
significant differences between participants with low and high perceived risk for 
developing T2DM for; gender, age, ethnicity, education level, previous history of 
gestational diabetes or frequency in GP visits (Table 4.1).  
 
Statistically significant differences between low and high perceived risk participants 




cardiovascular disease, GP-led discussions around diabetes and cardiovascular risks 




Table 4.1 Participant characteristics stratified by low and high perceived risk status 






P value Effect size 
Gender 
- Male n (%) 
- Female n (%) 
- Other n (%) 
 
 
64     (29%) 
155  (70.5%) 
1        (0.5%) 
 
16   (43%) 
20  (54.5%) 















6       (3%) 
24     (11%) 
32     (14%) 
24     (11%) 
134   (61%) 
 
2   (5%) 
5   (14%) 
3   (8%) 










Ethnicity n (%)^ 
(n=255) 
- NZ European 




































Education Level n (%) 
- High School Cert. 
- Certificate 
- Diploma 
- Bachelor’s degree 

































9      (4%) 




9    (26%) 










Previous gestational diabetes  
n (%) (n=244) 
- Yes 
- No 




















GP visit frequency n (%)  
(n=244) 
- Every 3 – 6 months 
- Once a year 

























GP testing for T2DM/ CVD n (%) 
(n=255) 
- Yes 




123  (56%) 
95     (44%) 
 
 
29  (78%) 







GP communication about 























Actual risk status^^^ 
- Low risk  
- Increased risk  
 
 
117  (53%) 
103  (47%) 
 






^No participants identified as Pacific Peoples. Asian includes all Asian ethnicity as well as South Asian 
^^BMI (kg/m2) = median (25th, 75th) 
^^^Actual risk status defined by Diabetes New Zealand ‘know your risk’ calculator; Low risk= risk score 
between 3 – 5. Increased risk= risk score > 5. 
*P–values determined by Mann–Whitney test and r=Z√n (effect size) calculated by Mann–Whitney Z score, 
where variables are ordinal. **P–values determined by Chi–square where variables are nominal; ***P–value 
reported from Fisher’s Exact test where assumptions of Pearson’s Chi–square are violated for 2x2 or 
Likelihood ratio for greater than 2x2 contingency Tables 
Significant results of P<0.05 are represented in bold. 
 
 
4.2 Perceived risk versus actual risk 
 
Figure 4.1 illustrates participant’s actual risk status (low vs increased) and their 
perceived risk status (low v high) of developing T2DM. There is a significant 
difference (P<0.001) between participant’s actual risk status as stratified by their 
risk perception, such that 86% (220/257) had a low perceived risk of developing 
T2DM, yet 47% (103/220) within this group had an increased actual risk of 










Figure 4.2 depicts risk perception and actual risk by gender; male (n=80) and female 
(n=175). A greater percentage of males than females had increased actual risk of 
developing T2DM; 59% (47/80) and 50% (87/175) respectively. Of the 59% of 
males who had an increased actual risk, 66% (31/47) had a low perceived risk of 
T2DM development. Similarly, of the 50% of women with an increased actual risk, 
82% (71/87) perceived their risk of T2DM development to be low. While a higher 
percentage of increased risk females perceived their risk to be low compared to 
males,  there were no statistically significant differences between the genders for 
actual risk status or perceived risk status.  While there were no significant 
differences between gender and perceived risk status in the low actual risk group, 
there were significant differences between gender and perceived risk status in the 
















Figure 4.2 Percentage of participants and their perceived and actual risk by gender 
Pearson’s chi-square analysis for Low Actual Risk (gender*perceived risk) = χ2(1) = 2.59, P*=0.10  
*P value reported from Fisher’s Exact test as assumptions of Pearson’s Chi–square violated for 2x2 
 




4.3 Analysis of the RPS–DD 
4.3.1 Reliability analysis  
 
Participants were categorised into low actual risk and increased actual risk as 
defined by the Diabetes New Zealand ‘Are you at risk?’ calculator as well as low and 
high perceived risk, as defined by section 2 of  questionnaire (Appendix 3) ‘How at 
risk do you believe you are for developing diabetes’.  Participants with a low actual 
risk of T2DM had a significantly higher score for perceived Personal Control 
compared with the increased actual risk group (3.8 (3.3–4.0) v 3.3 (3.0–3.5), 












This result suggests participants who had a low actual risk of developing T2DM 
perceived they had greater control over their health compared to participants with 
an increased actual risk. This was also observed in the participants who had low 
perceived risk, with a significantly higher score for Personal Control, compared to 
participants with a high perceived risk (3.5 (3.0–3.8) v 3.3 (3.0–3.5), P=0.01). 
Cronbach’s α, which represents the internal consistency of the variables within the 
personal control scale was 0.70, representing moderate reliability and internal 
consistency (Table 4.2). 
 
Participants who had a low actual risk had a significantly higher optimistic bias 
score, which suggests a higher perceived risk for developing diabetes compared 
with participants who an increased actual risk score (3.0 (2.5–3.0) v 2.5 (2.0–3.0), 
P<0.001) (Table 4.2).  This trend was also observed when stratifying participants by 
perceived risk; participants with low perceived risk had a higher Optimistic Bias 
score compared to participants with a high perceived risk, however this was not 
statistically significant (3.0 (2.5 –3.0) v 2.0 (2.0 – 3.0), P=0.18). The Cronbach’s α for 
the Optimistic Bias subscale was 0.71 (Table 4.2). 
 
The Comparative Disease risk subscale asked participants to rate how at risk they 
thought they were of getting each of the fourteen listed health conditions and 
diseases (such as diabetes heart disease, cancer and AIDS) .  
 
Participants who had a low actual risk had a significantly lower Comparative Disease 
risk score compared to participants with an increased actual risk (1.7 (1.5 –2.0) v 




had a lower risk of developing all diseases listed in the Comparative subscale 
compared to participants with an actual increased risk. This was also observed for 
participants with low and high perceived risk (1.8 (1.5–2.0) v 2.4 (2–2.5), P<0.001). 
The Cronbach’s α for the Comparative Disease risk subscale was 0.80, indicating 
very good reliability and internal consistency of the variables listed in the subscale 
(Table 4.2).   
 
There were no statistically significant differences between participants with low 
and increased actual risk, or participants with low and high perceived risk with 
respect to the Environmental Health risk subscale. The Cronbach’s α for this 
subscale showed high reliability (0.88) (Table 4.2).  
  
Significant differences in the Risk Knowledge subscale was observed for perceived 
risk but not for actual risk. Participants with low perceived risk had a significantly 
higher diabetes knowledge score compared to participants with high perceived risk 
for developing diabetes (8.0 (6.0–9.0) v 7.0 (6.0 –8.0), P<0.001). The Cronbach’s α 
for Risk Knowledge was 0.68, just under the 0.70 threshold for good internal 














Table 4.2 Reliability analysis of the Risk Perception Survey for Developing Diabetes (RPS–DD) stratified 











actual risk of 







































































1.7 (1.3 –2.1) 
 





*Actual risk of diabetes as defined by the Diabetes New Zealand ‘are you at risk’ calculator; low risk = score of 
3–5 and increased risk = score >5 
**Perceived risk of diabetes as defined by RPS–DD ‘how at risk do you believe you are for developing diabetes’ 
^ Mann–Whitney t test. Statistically significant results at P<0.05 is represented in bold. Values represented as 
median (25th, 75th quartiles).  
***Cronbach α = 0.70 and above is good , 0.80 and above is better and 0.90 and above is optimal reliability and 
internal consistency 
 
4.3.2 Diabetes Knowledge  
 
The scores from the Diabetes Knowledge section were analysed to see if there was 
a difference in diabetes knowledge between participants of low perceived risk and 
high perceived risk of developing diabetes (Table 4.3).  
 
Median score of participants with low perceived risk was 8.0 (6.0–9.0) compared to 




scores between participants with low and high perceived risk was  significant 
(U=3224, P=0.04 (2–tailed)), with knowledge of diabetes as assessed by the RPS–
DD being significantly higher in participants with low perceived risk of developing 
T2DM.  
 
On further analysis of individual RPS–DD Diabetes Knowledge questions (Table 4.3) 
only two questions were significantly different between participants who had low 
and high perceived risk.  The two questions were ‘Does having diabetes in pregnancy 
































P value Effect size 
(Phi) 




110 (50%) 14 (38%) 0.17* n/a 
Being Māori 169 (77%) 24 (65%) 0.12* n/a 
 
Eating a 
healthy diet  
215 (98%) 35 (95%) 0.27^ n/a 
 
 
Being of Pacific 
People 







146 (66%) 15 (41%) <0.01* 0.18 
Having a family 
history of 
diabetes 




Being over 65 
years of age2 
 








215 (98%) 37 (100%) 1.00^ n/a 
Pearson’s Chi square: 1 χ2 (1) = 9.03, P<0.01; 2 χ2 (1) = 7.12, P<0.01 
   
#To assess participant’s knowledge of T2DM risk they were asked the following question: Think about people in 
the general public and NOT about your own personal risk of getting diabetes. Which statement most closely reflects 
your view of how each item affects their risk for diabetes?   
Participants were asked to select ONE answer (either: increases the risk, has no effect on risk, decreases risk or 
don’t know) for each of the 10 items listed in Table 4.3 giving them a possible score out of 10 for each correct 
answer. 
(answers: Being Asian = increases risk; Being Caucasian = no effect; Being Màori = increases risk; Eating a healthy 
diet= decreases risk; Being of Pacific People = increases risk; diabetes during pregnancy=increases risk; family 
history of diabetes=increases risk, 65+yrs=increases risk; exercising regularly=decreases risk; controlling weight 
gain=decreases risk).  
 
*P–values reported from Pearson’s Chi Square  
^Fisher’s Exact Test P–value reported when assumptions of Pearson’s Chi Square not met 






Sixty–six percent (146/220) participants in the low perceived group correctly 
answered ‘increases the risk’ to the question ‘’Does having diabetes in pregnancy 
increase the risk of developing diabetes?’’ compared with 41% (15/37) of 
participants in the high perceived group (χ2 (1) = 9.03, P<0.01).  The effect size (Phi) 
was 0.18, which represented a small effect.  However, of note 78% (137/175) of 
females answered this question correctly, compared with only 22% (18/80) of 
males, suggesting gender could be influencing the result shown. The test for 
interaction effects did not report any significant effect between gender and the 
question on gestational diabetes (P=0.4). 
 
Seventy–eight percent (29/37) of participants in the high perceived risk group 
answered correctly ‘increases the risk’ to the question ‘’Does being over 65 years of 
age increase the risk of developing diabetes’’, compared with 55% (121/220) of 
participants in the low perceived risk group (χ2 (1) = 7.12, P<0.01). The effect size 
(phi) was 0.17,  indicating a small effect size.   
 
There was relatively poor knowledge around ethnicity (being Asian) as a risk factor 
for T2DM, with only 20% of participants with low perceived risk and 22% of 
participants with high perceived risk correctly answering ‘increases the risk’ to this 
question. A similar trend was also observed for ethnicity (being Caucasian) with 
only 38% of high perceived risk participants correctly answering ‘has no effect’ to 








Participants were asked if they planned to make diet or exercise changes in the 
future, that they believed would lower their risk of developing diabetes. This 
question was designed to assess participant’s motivation in lifestyle behaviour 
change. 
 
Of the 257 participants who answered this question 42% (108/257) said ‘yes’ they 
planned to make changes, whilst 58% (149/257) said they were not planning to 
make any lifestyle changes. When stratified by the participant’s perceived risk of 
developing T2DM, there was a significant difference between the groups, with 78% 
(29/37) of participants with a high perceived answering ‘yes’ to making lifestyle 
changes in the near future to reduce their risk, compared with 36% (80/220) of 
participants with low perceived risk (χ2 (1)=22.9, P<0.001). This was a medium  
effect size, (Phi) was –0.30 (Table 4.3).  
 
4.4 GP Communication, visits, and actual risk status 
 
There is a significant difference between GP communication and actual risk status 
(P=0.03), and GP-recommended tests and actual risk status (P=0.03), but not for GP 
visits and actual risk status (P=0.22) (Table 4.4). 
Overall, GP communication about T2DM/CVD risk to participants was low, with only 
21% (24/116) and 33% (42/128) of participants with low and increased actual risk 
receiving risk communication from their GP, respectively (χ2 (1) = 4.53, P=0.03) 




GP-recommended tests for T2DM/CVD was reported in 52% (60/116) of 
participants with low actual risk and in 66% (84/128) of participants with increased 
actual risk (χ2 (1) = 4.86, P=0.03) (Table 4.4). 
Spearman’s correlations between actual risk status and GP communication about 
risk are significant, yet weakly and negatively correlated (Rho(s) = –0.14, P=0.03). 
The same correlation relationship was seen between GP-recommended tests for 
CVD/T2DM and participants actual risk (Rho(s) = –0.14, P=0.03).  
Table 4.4 GP communication, visits & tests about T2DM/ CVD risk  stratified by participant actual risk 
status 





P value Rho(s)# 
GP Communication about 




























Frequency of GP visits 
(n=244) 
 
- Occasionally (every 
3 – 6 months) 
 
- Once a year 
 




























































*Actual risk score 







*Actual risk of diabetes as defined by the Diabetes New Zealand ‘Are you at risk?’ calculator; low actual risk = 
score of 3–5 and increased actual risk = score >5. Scores presented in medians (25th, 75th quartiles). 
^Pearson’s Chi–square: χ2 (1) = 4.53, P=0.03 Phi = –0.14; ^^Pearson’s Chi–square: χ2 (2) = 3.06, P=0.22; 
^^^Pearson’s Chi–square:  χ2 (1) = 4.86, P=0.03 Phi = –0.14 








4.4.1 Gender  
 
Significant differences were observed between males and female for; GP risk 
communication about T2DM/CVD risk, education level and RPS–DD Diabetes 
Knowledge scores (Table 4.5).  
 
Thirty-eight percent (29/80) of males reported having a discussion with their GP 
about the risks of diabetes and cardiovascular disease, however only 23% (40/175) 
females reported having a T2DM/CVD risk discussion with their GP (χ2 (1) = 5.51, 
P=0.02).  Of the 29 males who reported having a GP discussion about T2DM/CVD, 
76% (22/29) had an increased actual risk of developing T2DM according to the 
Diabetes New Zealand ‘are you at risk’ calculator compared with 55% (22/40) of 
females with an increased actual risk.  Furthermore, 34% (10/29) of males had a 
high perceived risk compared with 20% (8/40) of females who perceived their risk 
of developing T2DM to be high.  
 
Females had significantly more education than males, with 53% (94/175) of females 
having either a bachelors or post graduate qualification, compared with 44% 
(35/80) of males  (χ2 (5)= 11.02, P=0.05). 
 
Females also had significantly higher RPS-DD Diabetes Knowledge scores 8 (7,9) 
compared to males 7 (6,8) (U=3131.5, P<0.001, r =–0.15), although the effect size 







Table 4.5 GP information and risk status stratified by gender 
 Male Female P value* Effect size^ 
GP visit frequency (n=250) 
- Every 3– 6 months 
 
- Once a year 
 






















GP Communication about 



































































Actual risk (n=255) 













































Education level (n=255) 






- Bachelor’s degree 
 























































*Pearson’s Chi Square Test **GP Communication: χ2 (1) = 5.51, P=0.02 ; Education: χ2 (5) = 11.02, P=0.05 
^Cramer’s V effect size ; n/a – no effect size given for P>0.05 as significance not met 
# Mann–Whitney test: median (25th, 75th) U=3131.5, P<0.001 (2–tailed), r=–0.15 





4.5 Factors that influence perceived risk   
 
4.5.1 Potential variables that influence perceived risk   
 
Table 4.6 represents potential variables that may play a role in perceived risk of 
T2DM development.  Significant variables that correlated with perceived risk status 
(low vs high) included; GP communication about T2DM/CVD risk (P=0.001), 
BMI>25kg/m2 (P<0.001), family history of diabetes (P<0.001), exercising 
<2.5hrs/week (P=0.03), eating a diet high in fat and sugar (P<0.001), having a 
diagnosis of prediabetes (P<0.001), Comparative Disease risk (P<0.001), Personal 
Control (P=0.01), Optimistic Bias (P=0.001), and planned behaviour change to 
reduce diabetes risk (P<0.001) (Table 4.6). 
 
Table 4.6 Potential variables of perceived risk in developing T2DM 
Perceived Risk (n=244) Rs P–value (2–tailed) 
Demographic & health variables 
- Ethnicity 
- Gender 
- Education Level 
- Age 













Primary care variables 
- Frequency of GP visits 
- GP–recommended tests for T2D 
or CVD 
 

















Risk factors for T2D 















- Family history 
 
- Exercise <2.5hrs/week  
 















Beliefs on health & T2DM knowledge 
(from RPS–DD) 
 
- Comparative Disease risk 
 
- Environmental Disease risk 
 
- Personal Control 
 
- Optimistic Bias 
 
- Planned lifestyle modification to 
lower T2D risk 
 
































Spearman’s correlation analysis  
*Statistically significant results from P values <0.05 are represented in bold. 
 
4.5.2  A model of predictive variables that influence risk perception 
 
Table 4.7 represents the likelihood of significantly correlated variables predicting 
perceived risk of developing T2DM.  
 
There were five significant predictor variables (Table 4.7) in the logistic regression 
model of perceived risk including; having a diagnosis of prediabetes (P<0.01), eating 
a diet high in fat and sugar (P<0.01), having a family history of diabetes (P<0.001), 
having a low Comparative Disease risk (P<0.001) and planned lifestyle 








Table 4.7 A model of predictive variables that influence risk perception  
Predictive Variables  B Wald 
(X2) 
P–value OR 95% CI 






































- Exercise <2.5 
hrs/week 
 
- Diet high in fat and 
sugar 
 

















































0.57 – 9.08 
 
 
1.83 – 21.63 
 
 
3.00 – 34.47 
 
0.75 – 7.11 
 
Health risk beliefs 
 
- Optimistic bias 
(low) 
 




disease risk (low) 
 
- Planned lifestyle 
modification to 




















































0.14 – 1.58 
 
 
0.70 – 12.16 
 
 
0.01 – 0.15 
 
 
2.05 – 24.85 
*Statistically significant at P<0.05 level, represented by bold 
Binary logistic regression model: X2(10) = 109.7, P<0.001 
 
A test of the model, complete with predictors (Table 4.7) compared to an intercept–
only model was statistically significant χ2 (10, n=244) = 107.4, P<0.001.  
 
The model had an initial success rate of 85.2%, correctly classifying participants 
with low perceived risk 100% (208/208). The success rate of the model significantly 
improved after the addition of the above-mentioned predictor variables, increasing 





While there was a slight reduction in the correct classification of participants with 
low perceived risk, from 100% to 96% (199/208), there was a significant increase 
in correct classification of participants who perceived their risk to be high, 
increasing to 58% (21/36) from the original success rate of 0%.  This model 
explained 64% (Nagelkerke R2) of the variation in perceived risk.  
 
The odds ratio for having a diagnosis of insulin resistance was 8.97 (95% CI 1.61–
50.10), indicating, while holding all other variables constant, having a diagnosis of 
insulin resistance is 8.97 times more likely to result in an increased perceived risk 
of developing T2DM compared to not having a diagnosis of insulin resistance.  
 
Participants who reported eating a diet high in fat and sugar as well as a family 
history of T2DM had an odds ratio of 6.29 (95% CI 1.83–21.63) and 10.17 (95% CI 
3.00–34.47) respectively. This result suggests participants were at least 1.83 times 
and 3.00 times more likely to have an increased perceived risk of developing T2DM 
if they reported having a diet high in fat and sugar and a family history of T2DM, 
respectively.  
 
Participants who reported having planned behaviour modification to reduce their 
risk of T2DM had an odds ratio of 7.13 (95% CI 2.05–24.85). This result  indicates 
when holding all other variables constant, planned behaviour modification (in the 
form of diet and exercise) is 7.13 times more likely to result in an increased 






Chapter 5 – Discussion 
 
This study investigated the perception versus actual risk of developing T2DM in a 
New Zealand population. The validated RPS–DD questionnaire (Walker et al, 2009) 
was used to assess perceived risk and the Diabetes New Zealand ‘Are you at risk?’ 
calculator questions determined actual risk.  
 
The main aim of this study was to investigate an individual’s perception of risk and 
compare it to their actual risk of developing T2DM. A secondary aim of this study 
was to determine what factors influence an individual’s perception of risk. 
 
This chapter presents the discussion and interpretation of results obtained from the 
statistical analysis of the perceived versus actual risk data collected via an online 
questionnaire from 257 New Zealand participants. Section 5.1 explores the main 
aim of this research and discusses the findings of perceived versus actual risk of 
developing T2DM in this group of participants. Section 5.2 discusses the secondary 
aim which investigated predictors of risk perception including: having a diagnosis 
of prediabetes, consuming a diet high in fat and sugar, having a family history of 
diabetes, having a low Comparative Disease risk and planned lifestyle modification. 
GP communication about T2DM/CVD risk, frequency of GP visits, risk perception 
and age, health literacy and gender are also reviewed. Limitations of the study and 
future opportunities for research are considered in section 5.3 and 5.4, respectively. 






5.1 Perceived risk compared with actual risk of developing T2DM in a New 
Zealand population 
 
What was most striking from the results uncovered in this study was the large and 
significant disparity between participant’s perception of risk and their actual risk of 
developing T2DM. Overall, only 14% (37/257) of participants perceived they were 
at risk for developing T2DM, despite 53% (135/257) having an increased actual risk 
(a risk score ≥5) as defined by the Diabetes New Zealand ‘Are you at risk?’ calculator.  
 
Furthermore, of the 86% (220/257) who had a low perceived risk of developing 
T2DM, 47% (103/220) within this group had an increased actual risk of developing 
T2DM (Z=–9.43, P<0.001, r= –0.41). This result shows participants significantly 
underestimate their risk of developing T2DM, therefore we can reject our null 
hypothesis, and accept our alternative hypothesis such that: an individual’s 
perceived risk is not the same as their actual risk of developing T2DM in this sample 
of participants from a New Zealand population.  
 
Although striking, this is not a new finding. In fact, underestimation of actual T2DM 
risk is a common theme in diabetes risk perception literature (Table 2.2) (Graham 
et al., 2006; Guess et al., 2015; Guo, Tang, et al., 2019; Heidemann et al., 2019; Joiner 
et al., 2016; Kim et al., 2007; Kowall et al., 2017). Why this is, is not fully understood. 
Findings from the present study would suggest a need for greater discussion about 
T2DM risk in the primary care setting, given 76% (163/214) of participants who 
perceived their risk of developing diabetes to be low, reported not having received 




participants with a low perceived risk visiting their GP relatively frequently, with 
56% (120/214) visiting their GP at least once every three to six months.  
 
A similar finding was found in a UK-based study of 59 subjects where nearly half of 
the cohort had not had risk communication about their risk status from a GP, despite 
26 (44%) having a high risk as classified by the Diabetes UK risk assessment (Guess 
et al., 2015). Furthermore, of those participants who had been informed of their high 
risk status (42%) had significantly higher perceived risk scores (P<0.001) (Guess et 
al., 2015). A similar finding was seen in a nation-wide German-based survey of 2,327 
participants where researchers investigated diabetes knowledge and information 
needs (Heidemann et al., 2019). Results from Heidemann and colleagues (2019) 
showed determinants of perceived risk of diabetes included whether participants 
had been informed of their actual diabetes risk from their primary healthcare 
provider.  
 
In contrast, one study (Table 2.2) of 9,496 adults from the National Health & 
Nutrition Examination Survey (NHANES) showed an overestimation of perceived 
risk in a subsample of high perceived-risk participants (Yang et al., 2018). Of the 
9,496 participants, 28.4% (n=2,696) reported a high perceived risk for developing 
T2DM, however only 38.3% of this high perceived risk group had an actual risk of 
T2DM development, as measured by the American Diabetes Association guidelines. 
A reason for this overestimation could be because most participants (74.8%) had 





In another study (Table 2.2) only a weak association was observed between self-
reported actual risk factors and perceived risk of T2DM development in 255 older 
aged adults (57–79 years) with an increased risk for CVD and T2DM (Claassen et al., 
2011).  One reason for this weak association could be due to the close-ended 
questions used to assess causal beliefs of disease risk, which is thought to 
overestimate disease risk knowledge (Claassen et al., 2011).  
 
In another cross-sectional study of 324 Chinese and Hispanic or Latino adults (mean 
age 45.2 years) 52.7% of participants were simply unaware of their risk, although 
43% of participants had a high risk of developing T2DM as measured by the 
American Diabetes Association (ADA) guidelines.  
 
 
5.2 What influences an individual’s perception of diabetes risk? 
 
A secondary aim of this study was to investigate potential variables that influence 
an individual’s perception of risk to help understand mediators of risk perception. 
It is clear from examining perceived versus actual risk that an individual’s 
understanding of factors that lead to the development of T2DM is low. Why this is, 
is not clear. Possible explanations could be attributed to knowledge of risk factors 
that lead to T2DM development, or it could be attributed to a lack of 
acknowledgement of personal T2DM risk, especially given the absence of physical 
symptoms often associated with risk of T2DM development. The latter is difficult to 
comment on from the current study. Examining Diabetes Risk Knowledge, 




of 8 (6-9) out of a possible 10 for participants with low perceived risk and 7 (6–8) 
out of 10 for participants with high perceived risk.  Examining what influences an 
individual’s perception of T2DM risk will facilitate better strategies to enable a 
person to understand and hopefully implement changes in their life to reduce the 
risk of developing T2DM.  
 
The regression analysis highlighted significant predictors of risk perception 
including having a diagnosis of prediabetes, consuming a diet high in fat and sugar, 
having a family history of diabetes, having a low Comparative Disease risk and 
planned lifestyle modification.  These variables and their influence on an 
individual’s perception of risk are discussed below.  
 
Variables also discussed with regards to influencing an individual’s risk perception 
include GP communication around T2DM/CVD risk, frequency of GP visits, age, 
health literacy and gender.  
 
5.2.1 Previous diagnosis of prediabetes 
 
Results from this study showed having a previous diagnosis of prediabetes was a 
significant predictor of increased risk perception of developing T2DM (OR 8.97 
(95% 1.61–50.10), P<0.001).  This result is logical, given prediabetes/T2DM 
communication would be standard treatment of care for a patient with a clinical 
diagnosis of prediabetes, therefore it is expected the patient to have some 
knowledge or understanding from their GP of the risks associated with developing 




results with 78% (14/18) participants with a diagnosis of prediabetes, reporting 
having received GP-communication about CVD/T2DM risk.   
A similar trend was observed in a US-based study where a history of prediabetes in 
participants significantly predicted T2DM risk perception (unadjusted OR 16.15, 
P<0.001) (Joiner et al., 2016). Hivert and colleagues (2009) also demonstrated 
patients with metabolic syndrome (self-reported) were more likely to have a high 
perceived risk of developing T2DM compared with those patients who did not have 
metabolic syndrome (53% v 35%, P = 0.04).  An explanation for these findings was 
not discussed in the studies.  
 
5.2.2 Diet  
 
Participants who reported consuming a diet high in sugar and fat were significantly 
more likely to have a high perceived risk of developing T2DM in the current study 
(OR 6.29 (95% 1.83 –21.63), P<0.01).  
A similar trend was observed in a study by Yang et al (2018) who reported on nine 
risk factors participants perceived as increasing an individual’s risk for developing 
T2DM. Results showed participants ranked poor diet as the third highest risk factor 
for developing T2DM out of the nine risk factors. In contrast, a study involving 255 
participants from the Netherlands who were at risk for T2DM and CVD reported no 
significant association between unhealthy eating habits and risk perception of 
developing T2DM (Claassen et al., 2011). This could be because participants were 
also asked about risk factors that increase the risk of CVD at the same time, 




This was evident by the significantly lower mean risk scores for T2DM compared 
with CVD (Claassen et al., 2011).  
 
Guess et al (2015) showed a significant correlation between participant’s Healthy 
Eating Index (HEI) score, a measure of diet quality (with higher scores reflecting 
healthier diet quality), and their risk perception, such that participants with an 
increased perceived risk of developing T2DM also had significantly higher HEI 
scores (r2 = 0.243, P=0.048). This indicates having an awareness of risk influences 
healthier eating behaviours (Guess et al., 2015). In another study involving 255 
participants who were at risk for T2DM and CVD no significant association between 
unhealthy eating habits and risk perception of developing T2DM could be made 
(Claassen et al., 2011).   
 
5.2.3 Family history 
 
Family history was the largest predictor variable of perceived risk in the current 
study, with participants 10.17 times more likely to have a high perceived risk of 
developing T2DM if they reported having had a family history of diabetes (OR 10.17 
(95% 3.00–34.47), P<0.001).  This is not a new finding in the risk perception 
literature (Guo, Tang, et al., 2019; Heidemann et al., 2019; Hivert et al., 2009).   
 
In a German-based study of adults with an increased actual risk of developing T2DM 




(OR 2.10 (95% CI 1.06–4.16)) (Heidemann et al., 2019).  A similar observation was 
seen in a study of 176 mothers of preschool aged children in China, where 
participants who reported having a family history of diabetes (95% CI 0.40–1.31) 
had a higher perceived risk of developing T2DM. Family history of diabetes 
explained 12.5% of the variance of overall perceived risk (Guo, Tang, et al., 2019). 
While Joiner and colleagues (2016) also demonstrated the probability of a 
participant having an increased perceived risk of developing T2DM was significantly 
greater if they reported having a family history of diabetes. This significance did not 
translate into their logistic regression model of perceived risk (OR 2.07 (95% CI 
0.59–7.18), P=0.25).  
 
5.2.4 Comparative Disease risk 
 
Comparative Disease risk, while significant in the logistic model of determinants for 
perceived risk, the odds ratio was only 0.05 (95% CI 0.01–0.18). In contrast, Joiner 
and colleagues (2016) showed a significant odds ratio for Comparative Disease risk 
in their study of foreign born US Latino adults (n=135) (OR 60.56 (95% CI 10.71–
342.58) P<0.001) such that for every one-unit increment in Comparative Disease 
risk, participants were 10.71 times more likely to have a high perceived risk of 
developing T2DM. The significant and large odds ratio could be attributed to the fact 
that diabetes was the top-ranked health/disease condition in the Comparative 
Disease risk scale in this study. In contrast, a US-based study by Walker and 
colleagues (2003) who investigated risk perceptions in 535 nondiabetic physicians, 
diabetes was the 5th ranked health/disease condition.   This could be due to the 




Diabetes Risk knowledge scores compared with participants from the Joiner et al 
(2016) study (mean knowledge score 8.86 versus 4.36). The scores were out of a 
possible eleven.  
 
 
5.2.5 Planned behaviour modification  
 
Planned behaviour modification (in the form of diet and exercise) was the third 
largest predictor variable in the model of perceived risk in the current study (OR 
7.13 (95% CI 2.05–24.85), P=0.002).  This result is in contrast to a US-based study 
of 150 nondiabetic primary care patients who reported they were not more likely to 
make healthier lifestyle changes in the near future, despite having a high perceived 
risk of developing T2DM. Although it is worth noting this result was not significant 
(high 26% v low 29.2%, P=0.69) (Hivert et al., 2009). Hivert and colleagues (2009) 
noted one reason for this finding could be because this group showed significant 
(P=0.006) belief that doing exercise and following diets were a lot more effort.  
 
5.2.6 GP Communication about T2DM risk 
 
Communication and trust between patient and doctor with regards to an  
individuals’ disease risk is central to mediating behaviour change and therefore risk 
status (Heidemann et al., 2019).  
 
Overall, GP communication about T2DM/CVD risk to participants in this study was 




receiving risk communication information from their GP respectively (Appendix 3). 
The lack of GP communication around risk could be due to several factors, one most 
obvious being the time constraint facing health providers in a clinical setting, where 
15-minute appointments are often the norm and discussions beyond immediate 
symptoms and treatment options are not always possible.  
 
Another possibility is communication around risk is potentially communicated in a 
way that is not understood or remembered by patients. Since the inception of the 
information deficit model in the early 1970s, communication about health 
information from health professional to patient has been of the view –  
‘’if we arm patients and families with a deeper understanding of medical 
concepts on the cognitive level it will keep them healthy or compel them to treat 
their disease, leading to a healthier life’’ (‘’The Information Deficit 
Model’’(2018)). 
However, this model does not take into consideration the many factors which 
influences a patient’s health decision-making process, including their health literacy 
level (discussed in section 5.2.9).  
For example, factors influencing an individual’s health decision-making process are 
also impacted by financial, cultural, religious, and personal beliefs (‘The Information 
Deficit Model’’, 2018).   
 
An inability for the health professional to take pause and see through the ‘’lens’’ of 
how the patient views their health may be a missed opportunity to engage with the 
patient on a level beyond citing the latest medical research. By understanding a 




potential anxieties which may be preventing optimal health outcomes, offers 
opportunities for greater patient understanding and engagement in their treatment 
and ultimately, their health outcomes.  
 
A 6-month study of patients (n=32) who had recently been diagnosed with T2DM 
from GP practices around New Zealand found there was an opportunity to improve 
the effectiveness of communication during consultations (Dowell et al., 2018). 
Patients found the biomedical model of diabetes impersonal and difficult to relate 
to their personal circumstances. Some of the interactions between healthcare 
provider and patient illustrated this point, where the healthcare provider focused 
on getting the patient to understand they needed to do more physical activity, whilst 
not engaging in the potential barriers (looking after sick family/work) the patient 
faced in being able to do the exercise (Dowell et al., 2018).  
Dowell and colleagues (2018) offer insights for healthcare professionals to focus on 
a patient-centred approach regarding lifestyle advice and information on reducing 
diabetes risk, rather than conforming to a time–focused checklist aimed at simply 
informing the patient.  
 
Another possible explanation for the lack of discussion around GP-risk 
communication in this participant group could be simply, they were not viewed as 
being at risk of developing T2DM by their GP.  This explanation is supported by the 
correlation data between actual risk and GP communication about risk as well as 
GP-recommended tests for CVD and diabetes, whereby negative, weak correlations 
(Rho(s) = –0.14) were observed for these variables with actual risk (Table 4.5). Had 




expected to see an increase in GP-recommended tests as well as risk communication 
discussions. But the opposite was observed in the data.   
 
Obvious risk factors for the development of T2DM from a GP perspective that would 
typically be communicated in a clinical setting, (assuming the information had been 
offered/asked of participants during GP visits) would be; age, BMI, previous history 
of prediabetes and history of having had gestational diabetes in pregnancy.  
 
Most participants in this study were over the age of 55 years, which is a risk factor 
for the development of T2DM.  However, the total median BMI for participants was 
in the normal healthy range 24.4 (22.1,27.3). Additionally, only 7% (18/257) 
participants reported having prediabetes and only 3% (5/175) of female 
participants reported having had gestational diabetes during pregnancy.   
 
However, when analysing participant responses (n=244) to GP communication 
about risk of CVD/T2DM development as stratified by participant actual risk status, 
(defined by the Diabetes New Zealand ‘Are you at risk?’ calculator) there were 
significant differences between the participants actual risk and GP communication 
about CVD/T2DM. Sixty–six percent (87/128) of participants with an increased 
actual risk of developing T2DM (median actual risk score 7 (6,9)) reported not 
receiving any GP communication about T2DM risk during their GP visits compared 
with 79% (93/116) of participants with a low actual risk (median actual risk score 
3 (1,4)) (χ2 (1) = 5.15, P=0.02). Although this finding is significant, it is worth noting 





Effective communication between a doctor and their patient has many benefits, 
including increased patient understanding and adherence to treatments, reduced 
morbidity and increased quality of life (Mikesell, 2013). Furthermore, a patient–
centred approach to treatment through effective communication, has an ability to 
transform clinical outcomes for that patient (Mikesell, 2013). Over the last decade 
in New Zealand, there has been a focus on the importance of the patient-centred 
approach to clinical care.  
 
The Royal New Zealand College of GPs now endorses a new communication skills 
courses for GPs, which is founded on the principles of shared-decision making and 
stems from the ‘’Choosing Wisely Campaign’’, a global initiative aimed to improve 
patient-doctor communication so that patients are able to make the best decision 
that optimises their health outcomes (RNZCGP, 2018) .  
 
The importance of successful communication in delivering advice on lifestyle 
change in the clinical setting is becoming an increasing focus point (Coppell et al., 
2017). A recent study indicated a nurse-led communication style, supported by the 
primary GP can assist weight loss strategies in patients with prediabetes (Connor, 
Coppell, Gray, & Sullivan, 2019). Furthermore, Heidemann and colleagues (2019) 
demonstrated an independent determinant of a participant’s (moderate/high) 
perceived risk status was being informed about an increased diabetes risk by a 






5.2.7 Frequency of GP visits  
 
Another possibility as to why participants reported receiving minimal 
communication around CVD/T2DM risk from their GP could be attributed to the 
frequency of GP visits made by the participants. However, over half (59%) of  
participant’s reported visiting their GP every 3–6 months, which is relatively 
frequent when compared to a German–based study (n=2327), where only 37% 
reported having had a health check–up in the past two years (Heidemann et al., 
2019). 
 
When examining the possible relationship between GP frequency (3–6months, once 
a year, less than once a year) and GP communication about CVD/T2DM risk in the 
current study, 27% received communication vs 55% who did not. This finding was 
not significant, suggesting the frequency of GP visits did not impact on GP 
communication on CVD/T2DM risk.  This finding is similar to Heidemann and 
colleagues (2019) where participants who had been informed by a physician about 
their risk were more likely to have an increased perceived risk of developing T2DM 
(OR 3.27 (95% CI 1.51–7.07) P<0.05) despite only 37% of participants visiting their 
GP in the past two years.  
 
Given GP visits are not fully funded in New Zealand, access to health information 
regarding T2DM via a primary care setting may be a financial barrier for some New 
Zealanders. Alternative sources of T2DM health information available to the general 
public include campaigns, such as the 2015 Diabetes in Action campaign which 




well as encourage people to take action. This has been done through a range of 
initiatives including the launch of the online risk assessment tool (the one used in 
the current study), national roadshows as well as implementing a national Fitbit 
‘MoveMeant’ day, where people could sign up and commit to doing 10,000 steps a 
day. At time of publication, there does not appear to be any formal data available to 
evaluate the effectiveness of this campaign, however it has gained popularity, with 
the Fitbit MoveMeant challenge returning each year since 2015. While this campaign 
and its health information on T2DM was made freely available to New Zealander’s, 
the requirement of a Fitbit to take part in the MoveMeant challenge could have been 
a financial barrier for some people.  
 
In 2015, the Ministry of Health issued a 5-year plan aimed to improve access and 
quality to people-centred healthcare services for people at high risk or living with 
T2DM (Ministry of Health, 2015). This plan builds on the already established health 
promotion initiatives such as the Green Prescription. The 5-year plan acknowledges 
the increased prevalence of T2DM in Màori and Pacific peoples compared with New 
Zealand European and because of this, the strategies to reduce such disparities are 
guided by both the Màori Health Strategy He Korowai Oranga and ‘Ala Mo‘ui: 
Pathways to Pacific Health and Wellbeing 2014–2018. One of the six key principles in 
the 5-year strategic plan are to raise awareness and knowledge of T2DM through 
education-based programmes such as the implementation of Healthy Families NZ. 
This programme spans 10 New Zealand locations including over 1 million New 
Zealanders at increased risk for chronic diseases such as T2DM (Ministry of Health, 
2020).  The programme encourages improvements in health including increased 




alcohol-related harm (Ministry of Health, 2020). The systems approach of the 
Healthy Families NZ  is a collaboration between local iwi, councils and local Pacific-
led communities, with each of the 10 New Zealand locations offering a slightly 
different programme, tailored to that community (Ministry of Health, 2020). It is still 
too soon in the implementation phase of the progamme to determine the impact on 
risk factors or outcomes for T2DM (Matheson et al., 2018). 
 
5.2.8 Risk perception and age 
 
No significant association was seen between age and perception of risk in the 
current study (Table 4.1).  This finding differs from other studies, where a lower age 
has been associated with an increased perception of diabetes risk (Claassen et al., 
2011; Heidemann et al., 2019).  
 
A study of 639 German participants without T2DM, who had either a moderate or 
high perceived risk of diabetes were significantly associated with being younger in 
age (Heidemann et al., 2019).  Similarly, a study from the Netherlands of 255 
participants at risk for CVD and diabetes, found that participants who were 65 years 
or older had reduced risk perceptions, compared with younger participants. This 
finding was statistically significant in regression analysis model of perceived risk 
(OR –0.17, t 239 = –2.61, P=0.01) (Claassen et al., 2011).   
 
Why an increased risk perception has been associated with a lower age is not fully 
understood. One reason is thought to be due to poor knowledge around diabetes 




had relatively good diabetes risk knowledge, as indicated by their risk scores (Table 
4.2). However a reduced perception of diabetes risk has also been established in 
young persons, as was the case for 176 young Chinese mothers (mean age 31 years) 
of preschool aged children, where approximately 90% perceived their risk to be 
slight or non-existent, despite presenting with risk factors for T2DM (Guo, Tang, et 
al., 2019).  One reason for this finding could be due to the limited knowledge 
participants had around diabetes risk factors, with mean scores for the Diabetes 
Risk Knowledge subscale being 4.48  out of a possible 11. (Guo, Tang, et al., 2019) 
 
5.2.9 Participant health literacy 
 
Health literacy has been described as the ability for people to access and understand 
health information that enable them to make informed decisions about their health 
care (Ministry of Health, 2010).  New Zealand as a nation has relatively poor health 
literacy, with just over half (56%) of both Māori and non-Māori scoring below the 
minimum health literacy level in the Adult Literacy and Life Skills Survey (ALL) in 
2006 (Ministry of Health, 2010).  The number of Māori participants in the current 
study was small, with less than 1% of the participant numbers identifying as Māori.  
 
Participants in the current study displayed relatively good health literacy in the 
form of diabetes knowledge, with the median Diabetes Risk Knowledge score being 
8.0 (6.0 – 8.0) out of a possible 10. This score is probably reflective of the high 
education level of participants where 51% had either a graduate or post graduate 
qualification. Furthermore, participants were invited from a Massey University 




terms of knowledge and lifestyle factors associated with health. Participants who 
register for research studies typically have a vested interest in their own health and 
are subsequently more knowledgeable via exposure to research information and 
dissemination. Similar results have also been found in a previous study investigating 
health beliefs among a Hispanic prediabetic population, where an increased 
education level of participants corresponded to increased knowledge of diabetes 
risk (Shaak et al., 2018).  
 
Based on both the high education level of the participants in the current study, as 
well as their high knowledge of diabetes risk, participants’ health literacy does not 
appear to be a contributing factor to their low perceived risk of developing diabetes. 
Coupled with this, there were no statistically significant differences found in 
Diabetes Knowledge scores and participants with low or high perceived risk.  
Furthermore, diabetes risk knowledge was not a significant predictor variable to the 
model of perceived risk in this study. This is in contrast to a US-based study of 535 
nondiabetic physicians where Diabetes Risk Knowledge score was one of five 
independent predictor variables contributing to 33.7% of the variance seen in their 
risk perception of T2DM model (F=49.43, P<0.0001) (Walker et al., 2003). 
 
Following on from the results of the 2006 ALL survey, the Ministry of Health 
developed the Health Literacy Framework and review, aimed at building a health 
literate system, workforce and consumers of health services through a provider-
focused approach (Ministry of Health, 2015).  One of the six key components in the 
Health Literacy Framework was communication with consumers accessing health 




local GP practices, where those patients (42%) who had been informed of their risk 
by their healthcare provider had significantly higher knowledge scores (8.0± 3.0 v 
5.9 ±0.2, P<0.001) as well as a greater perceived risk (2.6± 0.1 v 2.0±0.1, P<0.001).  
 
5.2.10 Gender and risk perception 
 
There was no statistically significant association between risk perception and 
gender in this study with 80% of males and 89% of females perceiving their risk to 
be low (P=0.07). This finding is in contrast to a study of 150 non-diabetes primary 
care patients in Massachusetts, where 69% of women perceived their risk to be high 
compared with 44% of males (P=0.005) (Hivert et al., 2009).   
 
Similarly the KORA FF4 study also found women were more likely to perceive a 
higher risk of diabetes compared to men (Prevalence Rate (PR) = 1.2, 0.9–1.5) 
(Kowall et al., 2017). Why there were no significant differences between gender and 
risk perception observed in the current study is not fully understood. One possible 
explanation was the similar incidence of prediabetes between the gender (8% v 7%, 
P=0.86), which was the largest predictor variable in the perceived risk model of this 
study. Another possible explanation could be attributed to the balancing out of the 
two variables; Diabetes Risk Knowledge scores and GP communication about 
CVD/T2DM risk, such that significantly more females reported not receiving GP 
communication about CVD/T2DM risk compared to males (78% v 62%, P=0.02) but 
females had significantly higher Risk Knowledge scores compared to males (8 (7,9) 





Both increased GP communication about risk and higher Risk Knowledge scores 
have been associated with increased perceived risk of developing T2DM (Guess et 
al., 2015). 
 
5.3 Limitations of the study  
 
5.3.1 Risk calculator tools 
 
There are many different diabetes risk tools available to assess actual risk including: 
the ADA risk calculator (Bang et al., 2009), AUSDRISK (Chen et al., 2010), CANRISK 
(Robinson, Agarwal, & Nerenberg, 2011) and the Diabetes UK risk calculator among 
some of them.  
 
This study used the Diabetes New Zealand ‘Are you at risk?’ calculator tool due to 
the study examining a New Zealand population and their perception of risk.   
Comparing actual risk results against the gold standard measure of HbA1c and 
fasting plasma glucose, has shown the risk tool overestimates actual risk (Joiner et 
al., 2016). Additionally, participant feedback from this study highlighted the 
potential ‘black or white’ nature of the risk calculator tool, without taking into 
consideration the individual, or the way the questions are framed in the risk 
assessment calculator. For example, one participant in the current study was 
confused by the wording of the ‘yes’, ‘no’ question ‘I often eat foods high in fat and 
sugar’. This is not simply a ‘yes’ or ‘no’ answer, as some people eat a low sugar diet 
but may consume high quantities of good quality fats, as was the case with this 
participant. The interpretation of the question can result in incorrect answers which 





Another potential limitation of the risk calculator tool is that it does not consider 
some individuals, such as those who are endurance athletes. Comments from one 
participant reported –  
 ‘I’m going to look like someone who down-values their own risk, but my finding 
has been that as an endurance athlete (I mean running 30–50km a week, doing half a 
dozen marathons a year, half and full Ironman every year), with a BMI of around 26, I 
sometimes don’t score well in these sorts of things because of the nature of the 
questions.’’ – this participant scored in the increased risk category (risk score = 10) 
due to unmodifiable risk factors including; age, large baby (4+kg) at birth and a 
slightly elevated BMI. The participant goes on to say – ‘’…my perception of my risk IS 
different from your calculator…but in this instance, I might not be wrong!’’ 
 
Furthermore, there are elements of perception within the actual risk assessment 
tool. While questions from the Diabetes New Zealand ‘Are you at risk?’ tool have 
been slightly adapted in this study to reduce these perceptions, such as providing a 
quantifiable measure in the form of BMI for height and weight (section 3 of Appendix 
3) as well as add quantifiers to some of the lifestyle (diet and exercise) questions  





The sample of participants were drawn from a Massey University research database, 




projects. This database of participants is more likely to be a more health-aware 
sample of people, compared to the general population due to their previous 
experience and interest in volunteering for research. The health-information and 
the experiences (ie having anthropometric evaluations or blood analysis done) they 
would have been exposed to would most likely increase their health-awareness and 
knowledge as a result of volunteering.   
 
The participant sample in the current study was heavily weighted female, of a New 
Zealand European ethnicity, with 91% of participants from the Auckland region. 
Therefore extrapolating findings from this study would not be appropriate to the 
general population of New Zealand because T2DM is more prevalent in males than 
females (Joshy et al., 2009) and it is also over-represented in Māori and Pacific Island 
peoples (Jowitt, 2014).    
 
Additionally, there was a large difference between the number of participants in the 
low and high perceived risk groups. Therefore, caution should be used when 
interpreting the results. This is because it reduces the power of the statistical tests 
and therefore the strength of significant associations observed. Although similar 
differences have been observed in other studies; Guess et al (2015) reported 95% 
(55/58) participants with a low or moderate perceived risk and 5% (3/58) 
participants with a high perceived risk. A similar observation was also reported in 
Joiner et al (2016) where only 31% of participants (n=135) reported a 







The most significant limitation of this study was the lack of ethnic diversity of 
participants. Particularly because rates of both doctor diagnosed and undiagnosed 
T2DM in New Zealand are overrepresented in Pacific Peoples (15.4%) and Màori 
(9.6%) compared with New Zealand Europeans (6.1%) (Coppell et al., 2013). 
Furthermore, the burden of disease not only affects these ethnic groups 
disproportionality, they are also living with the disease earlier in life, with 
increasing incidence of T2DM now seen in children under 15 years according to a 
recent prospective Auckland study (Sjardin et al., 2018). 
 
 
5.4 Future direction and opportunities   
 
This study identified factors that influence an individual’s risk perception of 
developing T2DM. However more research is needed in the form of larger studies of 
perceived versus actual risk with a more heterogenous cohort of participants that 
would allow for examination of ethnicity differences in risk perception. Further 
research with larger cohorts would allow for extrapolation and identification of 
influences that would enable people to understand risk and make more informed 
decisions for implementing change.  
 
If the current global pandemic crisis of COVID-19 has taught us anything, it is how 
fortunate we are to live in an era of modern technology. The sudden increase in 
demand for telehealth services and remote clinical consults is an example of such 




tool for prediabetes and T2DM management in the long-term.  Consider a 
government-led initiative that funds telehealth services, patient portals coupled 
with automated and targeted healthcare information to high risk individuals. Such a 
concept would reduce barriers to healthcare services as well as allow high risk 
individuals to receive information relevant to them, in a stepwise and targeted 
manner. While further research is need in this area,  maximising technology to 
optimise patient health outcomes is a welcomed target priority in the recent 5-year 




To date, this is the first study that has demonstrated perceived risk of developing 
T2DM significantly underestimated actual risk in a cohort of 257 participants from 
a New Zealand population. These findings are supported by the current literature 
(Guess et al., 2015; Heidemann et al., 2019; Joiner et al., 2016; Kowall et al., 2017). 
Significant factors that were associated with a higher perceived risk include: 
increased GP-recommended tests for diabetes/CVD, increased GP-communication 
about diabetes/CVD risk, diagnosis of prediabetes and an increased BMI. Whilst 
insulin resistance and BMI have been well established in the literature for their 
association with increased risk perception (Claassen et al., 2011; Kowall et al., 
2017), the role of GP-based communication around risk of developing T2DM has not. 
While further studies are needed to corroborate these findings, it does offer an 
opportunity to consider how current T2DM risk communication in New Zealand 
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Appendix 1 – Participant Information Sheet (& consent) 
 
 
Study title:  
The PART 2DD Study –Perceived vs Actual Risk 
of Type 2 Diabetes Development in a New 
Zealand Population. 
 
Ethics committee ref: NOR 19/13 
 
Locality: Online questionnaire 
   
 
Lead investigator: Associate Professor Pamela 
von Hurst 
Contact: +64 (09) 414 0800  ext. 43657 
 
   
 
My name is Libby Evans and I am a Masters’ student at Massey University. As part of my 
Masters’ requirements I am investigating the perceived versus actual risk of developing 
type 2 diabetes in a New Zealand population.  
In order to gather this information I have developed an online questionnaire that I would 
like to invite you to take part in. Whether or not you take part is your choice.  
This Participant Information Sheet will help you decide if you’d like to take part in this 
online questionnaire.  It sets out why this study is being done, what your participation 
would involve, what the benefits and risks to you might be, and what would happen after 
the study ends.  You do not have to decide today whether or not you will participate in this 
study. Before you decide you may want to talk about the study with other people, such as 
family, whānau, friends, or healthcare providers.  Feel free to do this. 
By clicking ‘submit’ at the end of the questionnaire you will be consenting to 
participating in the research project. 
 
WHAT IS THE PURPOSE OF THE STUDY? 
Recent research estimates the current rate of type 2 diabetes in New Zealand to be 6.5%. 
This means approximately 210,000 New Zealand adults have type 2 diabetes (NZ Health 
Survey 2015/16, MOH 2016).  However, rates for pre–diabetes (also known as high blood 




Diabetes can result in long lasting health complications such as kidney disease, blindness 
and amputations. The importance of being able to prevent the development of type 2 
diabetes is important. An individuals’ awareness of their risk for the development of 
diabetes is essential for them to be able to make changes in their lifestyle, which is the first 
step in treating the disease.  
However, a number of studies that have investigated the relationship between an 
individual’s actual risk of diabetes development and their perceived risk have shown an 
underestimation of actual disease risk. 
To date no study has investigated this relationship in a New Zealand population. This study 
will investigate such a relationship. As well as offer insight into the development of lifestyle 
and behaviour interventions which could provide a more targeted approach around 
increasing awareness and knowledge of the disease in an aim to foster behaviour and 
lifestyle change in a New Zealand population. 
 
It is important to note:  
Type 1 and type 2 diabetes are very different conditions. Type 2 diabetes is the most 
common type of diabetes, and usually occurs in adulthood (but can usually be prevented by 
following a healthy lifestyle)1. Unlike type 1 diabetes, which is an autoimmune disease, 





WHAT WILL MY PARTICIPATION IN THE STUDY INVOLVE? 
We have chosen to study adults over the age of 18 years, who are residents or citizens of 
New Zealand and who are not currently pregnant. 
The online questionnaire is approximately 10 minutes in length. It is completely 
anonymous.  
At the end of the questionnaire you will be able to calculate your risk score of developing 
type 2 diabetes based on your answers given in the questionnaire. There will also be 
information provided about your risk score and what it means for you.   
To be eligible for the online questionnaire you must be: 
● A New Zealand citizen or resident 
● Over the age of 18 years. 
● Not currently pregnant 
● No previous doctor diagnosis of diabetes (type 1 or 2)  
● Be able to read and understand English 
 
WHAT ARE THE POSSIBLE BENEFITS AND RISKS OF THIS STUDY? 
Foreseeable risks, adverse–effects and discomforts that you may encounter by taking part 
in this study are minimal. Based on your answers to the online questionnaire, you will be 
provided with a risk assessment score of your risk for diabetes development, which could 
result in negative emotions if your risk score puts you at a higher risk for development of 
type 2 diabetes or if you find you have a higher weight range classification that you thought. 
Information on your risk score and what you can do about your risk score will be provided 
at the end of the questionnaire. 
Direct benefits of participating in this study include; an increased awareness and knowledge 
of the processes involved in research by actively participating in it. Additionally, you will be 
provided with a risk assessment score for your risk of diabetes development, as well as a 
relevant recommendation based on your risk assessment score.  
 
 
WHAT ARE MY RIGHTS? 
Participating in this study is completely voluntary and you are free to decline to participate, 





WHAT HAPPENS AFTER THE STUDY OR IF I CHANGE MY MIND? 
The anonymous data from the questionnaire will be collected through an online survey 
platform that only Massey University researchers are able access via login and password 
details. The data will then be stored at a secure location with the research team.  
Electronic data and records will be the responsibility of the Principal investigator. All data 
will be kept for 5 years, at which point it will be destroyed.   
All answers in the questionnaire will be saved up to the point of withdrawing, and any data 
previously entered will be deleted prior to analysis, manually by the research team. 
The results of this study will be published as a Masters’ thesis and a copy will be held by 
Massey University, available through the Massey University library. Publication in a peer–
reviewed journal will also be considered. 
As this survey is anonymous, you are unable to withdraw from the study after you have 
submitted it. 
 
WHO DO I CONTACT FOR MORE INFORMATION OR IF I HAVE CONCERNS? 
 
If you have any questions, concerns or complaints about the study at any stage, you can 
contact:  
Dr. Pamela von Hurst: Associate Professor, School of Sport, Exercise & Nutrition, Albany 
Phone: +64 (09) 414 0800 ext. 43657 
Email: P.R.vonHurst@massey.ac.nz 
 
Libby Evans: Masters Student, School of Sport, Exercise & Nutrition, Albany 
Email:libby.evans2012@gmail.com 
This project has been reviewed and approved by the Massey University Human Ethics 
Committee: Northern, Application NOR 19/13.  
If you have any concerns about the conduct of this research, please contact Associate 
Professor David Tappin (Committee Chair), Massey University Human Ethics Committee: 
Northern, email humanethicsnorth@massey.ac.nz 
If you want to talk to someone who isn’t involved with the study, you can contact an 





Phone:  0800 555 050 
Fax:   0800 2 SUPPORT (0800 2787 7678) 




1. Diabetes New Zealand. (n.d). Understanding type 2 diabetes. Retrieved on 8th May 
2019 from https://www.diabetes.org.nz/understand–type–2–diabetes 
2. Diabetes New Zealand. (n.d). Understanding type 1 diabetes. Retrieved on 8th May 

















Appendix 2 – Email advertisement 
 
Hi,  
Would you like to know what your risk for developing type 2 diabetes is? 
The School of Sport, Exercise and Nutrition at Massey University is conducting a study, via an 
online questionnaire, to look at the perception versus actual risk of developing type 2 
diabetes.   
The purpose of this questionnaire is to investigate the perceptions people have about type 2 
diabetes as well as calculating their actual risk of developing the disease. 
Approximately 210,000 New Zealand adults have type 2 diabetes and rates for pre–diabetes 
(also known as high blood sugar) are estimated to be much higher. Diabetes can result in long 
lasting health complications such as kidney disease, blindness and amputations. An individuals' 
awareness of their diabetes risk is essential to be able to make changes in their lifestyle to help 
reduce their risk of developing the disease. 
The study involves a short 10–minute online questionnaire.  
The questionnaire is open to anyone who: 
• Is a New Zealand citizen or resident  
• Does NOT currently have a diagnosis of type 1 or 2 diabetes  
• Is over the age of 18 years 
• Is NOT currently pregnant 
Benefits in participating in the questionnaire include:  
• Obtaining your own personal risk score of developing type 2 diabetes, as well as 
information about your risk score.   
• You will be contributing to valuable research, with results of the research available on 
the below website early next year.  








Appendix 3 – Perceived v Actual risk of developing T2DM questionnaire  
Perceived risk versus actual risk of 
developing type 2 diabetes 
 
 




   
Thank you for taking the time to complete this anonymous questionnaire. It will take 
approximately 10 minutes.    
    
The purpose of this questionnaire is to investigate the perceptions people have about type 2 
diabetes as well as their actual risk of developing the disease. 
  
Approximately 210,000 New Zealand adults have type 2 diabetes and rates for prediabetes 
(also known as high blood sugar) are estimated to be much higher. Type 2 diabetes can result 
in long lasting health complications such as kidney disease, blindness and amputations. An 
individuals' awareness of their diabetes risk is essential to be able to make changes in their 
lifestyle. 
  
 This questionnaire will calculate your actual risk of developing type 2 diabetes.  Information 
about your risk score will be provided, and what you can do if you have a high risk score. 
     
  
Please answer either YES or NO to the following screening questions to see if you meet the 
requirements to participate in this study. 
     
By clicking ‘submit’ at the end of this questionnaire, you consent to participating in this 







 Do you currently have a diagnosis of diabetes (either type 1 or type 2)? 
o Yes  




 Are you currently pregnant? 
o Yes  




 Are you under 18 years of age? 
o Yes  




 Are you a New Zealand citizen or resident? 
o Yes  
o No  
 
End of Block: Introduction and screening 
 





Q1 How old are you?  
o 18 – 24 years  
o 25 – 34 years  
o 35 – 44 years  
o 45 – 54 years  














Q4 What is your gender? 
o Male  
o Female  







Q5 What is your ethnicity? 
o New Zealand European  
o Māori  
o Pacific Island  
o Asian  
o Prefer not to answer  









Q7 What is the highest education level you have achieved? 
o High school qualification  
o Certificate  
o Diploma  
o Bachelors degree  
o Post graduate qualifications (such as a Masters or PhD)  







Q8 Have you ever been diagnosed with prediabetes or insulin resistance (high blood sugars)?  
o Yes  
o I don' know  




Q9 Have you been diagnosed with gestational diabetes (diabetes that occurs during 
pregnancy)? 
o Yes  
o I don't know  
o No  




Q10 How often would you visit your GP or healthcare provider for a medical appointment? 
o Often (more than once a month)  
o Occasionally (once every 3 – 6 months  
o Once a year  
o Less than once a year  







Q11 When you visit your GP or healthcare provider, have they suggested doing a check–up for 
heart disease or diabetes (such as doing blood tests to test your sugar or cholesterol levels, or 
by measuring your blood pressure or weight)? 
o Yes  
o No  




Q12 Does your doctor ever talk to you about the risks of heart disease and/or diabetes? 
o Yes  
o No  
o I don't know  
o Not applicable  
 
 





End of Block: Section 1 – Health & Demographic Questions 
 
Start of Block: Perception of Risk 
 
    Section 2: The next set of questions ask about what you think your risk or chance of getting 
diabetes is  (Qu 13 – 16 based on the RPS–DD survey by Walker et al, 2003 (Revised 2009) ©E.A Walker 2009; (Qu 







Q13 For EACH of the following statements, please select ONE option that best reflects your 
opinion 
 Strongly Agree Agree Disagree Strongly Disagree 
I feel that I have 
little control over 
risks to my health  o  o  o  o  
If I am going to 
get diabetes, 
there is not much 
I can do about it.  
o  o  o  o  
I think that my 
personal efforts 
will help control 
my risks of getting 
diabetes.  
o  o  o  o  
People who make 
a good effort to 
control the risks 
of getting 
diabetes are much 
less likely to get 
diabetes.  
o  o  o  o  
Compared to 
other men or 
women of my 
same age, I am 
less likely than 
they are to get 
diabetes.  
o  o  o  o  
Compared to 
other men or 
women of my 
same age, I am 
less likely than 
they are to get a 
serious disease.  








Q14 Considering EACH of the following diseases, please rank how at risk you believe you are 
for developing each of these conditions, where 1 = almost no risk and 4 = high risk 
 1 (almost no risk) 2 (slight risk) 3 (moderate risk) 4 (high risk) 
Heart disease  o  o  o  o  
High blood 
pressure  o  o  o  o  
Arthritis  o  o  o  o  
Cancer  o  o  o  o  
Diabetes  o  o  o  o  
Stroke  o  o  o  o  
Hearing loss  o  o  o  o  
Infections 
requiring medical 
treatment  o  o  o  o  
Blindness  o  o  o  o  
Osteoporosis  o  o  o  o  
Asthma  o  o  o  o  
Kidney failure  o  o  o  o  
Foot amputation  o  o  o  o  








Q15 Considering the following environmental risks, please rank how at risk you believe you are 
to injury/death as a result of: 
 1 (almost no risk) 2 (slight risk) 3 (moderate risk) 4 (high risk) 
Driving or riding in 
a vehicle  o  o  o  o  
Being exposed to 
air pollution  o  o  o  o  
Being involved in 
violent crimes  o  o  o  o  
Exposure to 
pesticides  o  o  o  o  
Exposure to 
extreme weather 
conditions  o  o  o  o  
Exposure to 
household 
chemicals  o  o  o  o  
Exposure to 
secondary smoke  o  o  o  o  
Being exposed to 
medical  x–rays or 
radiation  o  o  o  o  
Consuming illegal 





Q16 We would like you to think about people in the general public and NOT about your own 




item affects their risk for diabetes? (ie for EACH of the following statements, please tick ONE 
option which best reflects your opinion). 
 
Increases or 
raises the risk 
Has NO effect on 
risk 
Decreases or 
lowers the risk 
Don't Know 
Being Asian  o  o  o  o  
Being Caucasian 
(white)  o  o  o  o  
Eating a healthy 
diet  o  o  o  o  
Being Māori  o  o  o  o  
Being  of Pacific 
Peoples  o  o  o  o  
Having had 
diabetes during 
pregnancy  o  o  o  o  
Having a family 
history of diabetes  o  o  o  o  
Being 65 years of 
age or older  o  o  o  o  
Exercising 
regularly  o  o  o  o  
Controlling weight 








Q17 For each statement below, please tick the option which best reflects your opinion about 












following a diet 
take a lot of 
effort  







o  o  o  o  o  
Benefits of 




effort to do it  





Q18 What do you think your risk or chance is for getting diabetes over the next 10 years? 
Please select one option  
o Almost no chance  
o Slight chance  
o Moderate chance  







Q19 Are you planning to make changes in any lifestyle behaviours (such as diet or exercise) in 
the near future that you believe will lower your chances of getting diabetes? 
o Yes  
o No  
 
 






Start of Block: Actual Risk 
 
 Section 3: Please answer each question in this section.  This section will determine your Actual 





Q20 I do very little physical activity (ie less than 2.5 hours per week)  
o Yes  
o No  
 
 






Q21 I often (ie most days of the week) eat foods that are high in fat and sugar? 
o Yes points  
o No points  
 
 






Q22 There has been type 2 diabetes in my family? (type 2 diabetes is the most common type 
of diabetes, most often seen in adulthood and it is usually affected by lifestyle choices such as 
exercise and diet) 
o Yes  
o No  
 
 






Q23 I am of Māori, Pacific Island, South Asian or Middle Eastern decent? 
o Yes  
o No  
 
 






Q24 I have given birth to a baby weighing more than 9 pounds (4 kg) or I have had high blood 
sugars in pregnancy. 
o Yes  
o No  
o Not applicable  
 
 






Q25 I am between 35 yrs and 64 yrs of age. 
o Yes =  
o No =  
 
 






Q26 I am 65 years or older. 
o Yes =  
o No =  
 
 






Q27 Is your BMI (body mass index) over 25? To work out your BMI, please click here 
o Yes  
o No  
 
 





End of Block: Section 3 – Actual risk of type 2 diabetes development (www.diabetes.org.nz) 
 




 Your Actual Risk Score is :  $(gr://SC_42BrWXg8ovsczEp/Score)  
    
  
  
    
Please click the 'submit' button to find out what your score means.    
   
 
 
A score of between 3 and 5:  You are at low risk for having type 2 diabetes now, 
however you may be at an increased risk in the future. 
A score of greater than 5: You are at an increased risk for having or developing 
type 2 diabetes now. Only your doctor can confirm a diagnosis of type 2 diabetes. It 
is recommended that you contact your local GP for further information and advice. 
  
If you have an increased risk for developing type 2 diabetes, rest assured 
there are lifestyle changes you can make to help reduce your risk. 
  
To try and avoid type 2 diabetes developing, make the following changes 
as recommended by Diabetes New Zealand: 
Stay physically active and get regular exercise. Aim for at least 30 minutes of 
moderate physical activity each day. Brisk walking, swimming, cycling, Marae 
activities, dancing and mowing the lawns all count. Remember you don’t have 
to do all of your daily exercise at once. For example, three brisk walks for 10 
minutes in the day may be more manageable than one of 30 minutes. Eat 
healthy food. Keep your weight in a healthy range. 
(Sourced directly from Diabetes New Zealand; https://www.diabetes.org.nz/are–
you–at–risk–1) 
  
For more information on types of healthy foods as well as how to manage a 






If you are still concerned about your risk of developing type 2 diabetes, it is 






















Appendix 4 – Diabetes New Zealand “Are you at risk?’’ calculator 
 
Diabetes New Zealand – ‘Are you at Risk Calculator 
(sourced from https://www.diabetes.org.nz/are–you–at–risk) 
Find out if you are at risk  
 























I have had a baby weighing more than 9lbs (4kg) or high blood glucose during 








I am over 65 years of age No Yes  
0
 
Score 3–5: You have probably at low risk for having type 2 diabetes now. However, 
you may be at a higher risk in the future. 
Score 6 or more: You are at greater risk of having type 2 diabetes. Only your health 















Appendix 5 – Risk Perception Survey for Developing Diabetes (RPS–DD) Scoring 











Appendix 5 continued… Risk Perception Survey – Developing Diabetes (RPS–DD) 
















































Appendix 6 – Risk Perception & Lifestyle Modification – Diabetes Development 
(RPLM–DD) (Kim et al 2007) 
 
 
 
